https://www.pharmaradar360.com hourly 1 https://www.pharmaradar360.com/news hourly 0.95 https://www.pharmaradar360.com/regulators daily 0.9 https://www.pharmaradar360.com/trials daily 0.85 https://www.pharmaradar360.com/pipeline daily 0.9 https://www.pharmaradar360.com/drug-approvals daily 0.9 https://www.pharmaradar360.com/journals weekly 0.8 https://www.pharmaradar360.com/pharma-companies weekly 0.8 https://www.pharmaradar360.com/specialties weekly 0.8 https://www.pharmaradar360.com/sources weekly 0.8 https://www.pharmaradar360.com/newsrooms weekly 0.8 https://www.pharmaradar360.com/pharma-tools weekly 0.8 https://www.pharmaradar360.com/pharma-communities weekly 0.75 https://www.pharmaradar360.com/pro weekly 0.75 https://www.pharmaradar360.com/tools weekly 0.7 https://www.pharmaradar360.com/about monthly 0.5 https://www.pharmaradar360.com/privacy yearly 0.35 https://www.pharmaradar360.com/support monthly 0.35 https://www.pharmaradar360.com/disclaimer yearly 0.35 https://www.pharmaradar360.com/drug/pembrolizumab daily 0.9 https://www.pharmaradar360.com/drug/semaglutide daily 0.9 https://www.pharmaradar360.com/drug/tirzepatide daily 0.9 https://www.pharmaradar360.com/drug/trastuzumab-deruxtecan daily 0.9 https://www.pharmaradar360.com/drug/osimertinib daily 0.9 https://www.pharmaradar360.com/drug/nivolumab daily 0.9 https://www.pharmaradar360.com/drug/dupilumab daily 0.9 https://www.pharmaradar360.com/drug/risankizumab daily 0.9 https://www.pharmaradar360.com/drug/lecanemab daily 0.9 https://www.pharmaradar360.com/drug/atezolizumab daily 0.9 https://www.pharmaradar360.com/article/glass-pumpkin-patch-at-the-arboretum-d02dfdd728c01c10 2026-09-18T16:48:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-ev-dose-is-not-what-it-seems-quantitative-mismatch-between-particle-number-f47a7c5a1a3284b4 2026-09-18T16:29:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/semi-mechanistic-joint-population-pharmacokinetic-modeling-of-the-novel-antitube-ebec18c2810c96c6 2026-09-18T16:02:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-options-buzz-uthr-nmra-ewtx-904141373556fd38 2026-09-18T15:46:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-have-to-be-bilingual-to-participate-in-circle-u-activities-c8b706a758c482a8 2026-09-18T15:39:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-trial-suggests-lsd-could-help-treat-anxiety-one-patient-meets-god-the-o-cb4c52a47721d100 2026-09-18T15:30:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/emirates-biotech-and-partner-launch-uae-organic-waste-to-biogas-pilot-7528d116c86d5b63 2026-09-18T15:24:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-circle-u-helped-me-define-my-career-path-81b7d487eea3e910 2026-09-18T15:21:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-stock-craters-30-on-drug-trial-setback-its-failure-could-be-this-biotech-s-56a2fa84d3bb02c3 2026-09-18T15:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-adds-1-1b-to-biotech-fund-84639908b0e2b140 2026-09-18T15:06:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-receives-positive-chmp-opinion-for-cosentyx-in-polymyalgia-rheumatica-p-72f0f6aa86cf0f0b 2026-09-18T15:04:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-20-anos-sin-lopez-se-renueva-el-reclamo-por-verdad-y-justicia-4b7984b231467d6e 2026-09-18T15:02:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-adrs-slip-in-us-trading-as-biotech-splits-5d79b846c95a7a75 2026-09-18T15:00:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/37-000-ai-agents-are-running-a-virtual-biotech-at-stanford-486a0da87125e24a 2026-09-18T14:52:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-sees-large-volume-increase-after-analyst-u-02e90aaa7ef82c7c 2026-09-18T14:42:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-rebate-timing-distorts-a-pharmacy-s-340b-books-3fc20171d90a422c 2026-09-18T14:41:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-price-target-raised-to-32-00-e4b617ea41d02a41 2026-09-18T14:38:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidance-covid-19-test-validation-approved-products-8740f36d3b2718d0 2026-09-18T14:38:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-catalyst-stocks-with-binary-events-coming-up-0e77c7de51362b23 2026-09-18T14:36:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/spn-exclusive-an-early-look-at-mcc-s-completed-3-million-biotech-lab-68ba636d342ac5cf 2026-09-18T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-gene-therapy-for-sanfilippo-syndrome-type-a-ddacc8fe3f2a7e07 2026-09-18T14:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-how-can-sponsors-respond-to-clinical-trial-customs-delays-6f1b84efeb049467 2026-09-18T14:24:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-debate-defesa-da-democracia-confrontos-e-estrategias-de-comunicacao-em-reun-9eb7532f7d41d72a 2026-09-18T14:23:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-hearing-psychedelics-launch-needs-balanced-regulation-without-limiting-acces-81cc63fd87c8c2d5 2026-09-18T14:22:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/fierce-pharma-asia-china-deals-safe-from-coins-key-wclc-data-legend-s-new-ceo-c23fdc3b607774da 2026-09-18T14:20:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-the-pharmtech-ai-pulse-check-expert-video-series-c9a61784abb684de 2026-09-18T14:20:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/nordic-perspectives-on-education-a-two-book-launch-335960b186ef8c7d 2026-09-18T14:06:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-biotech-ai-system-advances-drug-discovery-with-37-000-agents-6df6d3ca1fbffbc8 2026-09-18T14:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-closer-look-at-the-50-billion-rural-health-transformation-program-76a13771919bcee8 2026-09-18T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bucks-county-biotech-hub-and-doylestown-hospital-land-state-grants-for-new-proje-8665c163a0e7a8bc 2026-09-18T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-targets-oral-macrocycles-with-1-4bn-orbis-partnership-6671ed6a26e6a1c2 2026-09-18T13:52:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-drawing-fresh-attention-to-takeda-pharmaceutical-tse-4502-8ed4853f5f8b35eb 2026-09-18T13:44:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-expands-its-boston-footprint-with-new-research-center-61c8eaa9d2c59da9 2026-09-18T13:43:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-growing-world-of-biopharma-prediction-markets-765a66b0e486f7cc 2026-09-18T13:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/veradermics-buy-before-the-catalysts-nyse-mane-5202da45b7aa63c8 2026-09-18T13:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shingles-can-cause-severe-chronic-pain-new-research-on-how-exosomes-alter-neuron-2a6301bdbff0f775 2026-09-18T13:33:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-westchester-fairfield-leaders-advocate-for-health-and-raise-funds-critical-for-78121da21d239558 2026-09-18T13:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seqens-brings-its-personal-care-and-custom-specialties-activities-together-withi-48e0fd6157eea57e 2026-09-18T13:27:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/reasons-to-add-west-pharmaceutical-stock-to-your-portfolio-now-a987741149fa9bd2 2026-09-18T13:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-this-biotech-just-nearly-erased-its-one-day-50-pop-69c3a9008e5f3dad 2026-09-18T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aces-alumna-employs-biotech-to-create-sustainable-livestock-production-bcccea6733969c2c 2026-09-18T13:12:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/stanford-virtual-biotech-links-target-expression-patterns-to-higher-drug-success-4f2cc92095f808d2 2026-09-18T13:04:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/state-fiscal-conditions-context-on-medicaid-budgets-for-fy-2027-a4d0ffddaeb7db7d 2026-09-18T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chutes-ladders-legend-poaches-novartis-vet-to-boost-commercial-potential-e80965543b112e35 2026-09-18T12:53:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/auszeichnungen-fur-herausragende-forschung-und-innovation-in-der-infektiologie-2e2b4d68c515c033 2026-09-18T12:46:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/canaccord-genuity-group-increases-ultragenyx-pharmaceutical-nasdaq-rare-price-ta-7cfbe3170174b2c9 2026-09-18T12:45:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharma-to-cut-98-jobs-as-smartdose-production-winds-down-in-arizona-47ebb0bb9de0badd 2026-09-18T12:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unc-global-affairs-encourages-more-study-abroad-in-japan-b882c10bbd673b89 2026-09-18T12:34:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-cells-that-cheat-death-and-rebuild-damaged-tissue-2ba232951401badc 2026-09-18T12:30:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-highlights-new-real-world-data-supporting-the-effectiveness-of-vraylar-ca-4c1f376b38b218c5 2026-09-18T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lakewood-amedex-starts-phase-2a-trial-for-nu-3-to-treat-diabetic-foot-ulcers-wit-e4b94f11fe4c68f0 2026-09-18T12:24:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/jahresbericht-des-krebsregisters-der-kantone-zurich-zug-schaffhausen-und-schwyz-63636ce70813c644 2026-09-18T12:14:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/cantor-fitzgerald-forecasts-strong-price-appreciation-for-ultragenyx-pharmaceuti-a94686663212042b 2026-09-18T12:13:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-gel-for-infected-diabetic-foot-ulcers-is-ready-for-a-clinical-trial-9baca5ba6094011d 2026-09-18T12:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lakewood-amedex-biotherapeutics-announces-irb-approval-and-clinical-site-readine-6c633ac91c89ca34 2026-09-18T12:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-pharmaceuticals-owning-it-gives-you-a-stake-across-biotech-nasdaq-lgnd-a5490902b4f252f8 2026-09-18T12:06:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/countering-motor-neuron-degeneration-with-base-editing-155eca28b20c8601 2026-09-18T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/establishment-of-two-new-on-site-laboratories-approved-465c999c4a9c1229 2026-09-18T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/signatm-artist-and-signatm-artist-evo-b43f2d2ea4307776 2026-09-18T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-seizes-adulterated-food-worth-rs-56-36-lakh-banned-gutkha-worth-rs-20-2-b25b754ddcb9cba2 2026-09-18T11:38:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukri-space-lab-hosts-first-uk-pm-and-head-of-nato-meeting-484a0b72310be070 2026-09-18T11:33:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-congratulates-ultragenyx-on-u-s-fda-approval-of-fayuvitm-gen-08da3da710ebe595 2026-09-18T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/das-universitatsklinikum-heidelberg-ist-grundungsmitglied-von-medi-cus-bff2845ac3e34d06 2026-09-18T11:29:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/suny-funding-to-advance-tech-that-could-improve-patient-care-9e34ce94de8cee0f 2026-09-18T11:22:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-unveils-a-new-five-year-plan-for-developing-pharmaceutical-industry-44919095069d11e6 2026-09-18T11:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-executive-mfn-deals-aren-t-enough-q-a-with-joe-cunningham-48c869a29e6c3e7f 2026-09-18T11:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/addressing-mfn-innovation-concerns-568aea26781afe55 2026-09-18T11:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-ai-agents-satisfy-cgmp-documentation-requirements-609a4915047af303 2026-09-18T11:04:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/shining-a-light-on-uterine-cancer-rising-incidence-and-mortality-persistent-ineq-b6df0ffb13807c1d 2026-09-18T11:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-to-report-results-for-third-quarter-2026-on-october-29-2026-915d65a4fe2302cb 2026-09-18T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-us-weighs-allowing-most-pharma-licensing-deals-with-china-sources-say-d48516f28aaf5220 2026-09-18T10:56:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-us-weighs-allowing-most-pharma-licensing-deals-with-china-sources-say-9eef7f5883b17b66 2026-09-18T10:55:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-receives-positive-eu-chmp-opinion-for-keytruda-pembrolizumab-plus-padcev-e-9dda3e8e04d1e9ea 2026-09-18T10:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chmp-recommends-eu-approval-of-roche-s-ocrevus-for-children-and-adolescents-with-7987b36e70396aa4 2026-09-18T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-launches-your-hive-of-whole-health-to-support-whole-person-care-for-people-6fb49d94bbe3b4f2 2026-09-18T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-targets-3-5-trillion-yuan-pharmaceutical-industry-by-2030-ea3e6220b6b84bbf 2026-09-18T10:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-sellas-immunotherapy-study-long-delayed-will-end-in-failure-4f39356374c8bccb 2026-09-18T10:28:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/investors-pour-over-30b-into-longevity-biotech-companies-8159bc55d8a873ce 2026-09-18T10:15:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuvectis-pharma-haisco-licensing-deal-revitalises-biotech-but-no-rush-to-invest-9e5025881f0236a4 2026-09-18T10:15:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/chicago-biotech-inomagen-lands-up-to-2-9m-for-gene-therapy-targeting-afib-2314e0a3b1c7a48d 2026-09-18T10:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investors-pour-over-30b-into-longevity-biotech-companies-fe16e000e0bbdcc4 2026-09-18T10:13:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/market-movers-rx-west-pharmaceutical-services-leads-gainers-d11ab73a9d464311 2026-09-18T10:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-the-latest-with-mfn-pricing-and-what-it-means-to-pharma-611640f35e9de0d0 2026-09-18T10:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-india-acquires-pfizer-s-minipress-brands-for-150-million-717f175a2a74699d 2026-09-18T10:04:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/alterity-therapeutics-nasdaq-athe-to-outline-msa-drug-plans-at-asx-smidcaps-conf-1fca461c030238b6 2026-09-18T10:03:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-pauses-phase-3-depression-trials-after-psychosis-events-c474442598d818f4 2026-09-18T10:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clear-labels-act-stripped-of-key-provisions-before-senate-vote-81d6841a7d217e7c 2026-09-18T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clear-watering-down-drug-transparency-bill-stripped-of-critical-provisions-ahe-5a903264c20ac795 2026-09-18T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-key-to-success-is-being-willing-to-understand-the-energy-system-9887c5050e48720d 2026-09-18T09:57:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/these-blood-thinners-may-have-an-unexpected-benefit-for-alzheimer-s-patients-daa8fc27301148bf 2026-09-18T09:48:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/cantor-fitzgerald-maintains-overweight-rating-on-ultragenyx-pharmaceutical-39-pr-90bfb8ef4162d81e 2026-09-18T09:41:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-bets-on-ai-designed-macrocycles-in-orbis-oral-drugs-deal-3d2fb0a79abc2e12 2026-09-18T09:28:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/grunenthal-prices-850m-euros-of-notes-to-refinance-and-fund-expansion-51639ee1c0a91b88 2026-09-18T09:24:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapport-therapeutics-inc-rapp-stock-analysis-a-clinical-stage-biotech-with-a-49-bb04e31254be6de9 2026-09-18T09:19:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/celcuity-inc-celc-stock-analysis-unpacking-an-89-32-potential-upside-in-biotech-ed1c905c6f09d8a1 2026-09-18T09:19:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/oruka-therapeutics-inc-orka-stock-analysis-a-58-6-potential-upside-beckons-biote-d636f4afe1bf33f2 2026-09-18T09:19:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/oric-pharmaceuticals-oric-stock-analysis-a-60-upside-potential-with-strong-buy-r-8623ff2cd166514b 2026-09-18T09:19:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/primo-capital-launches-biotech-venture-fund-for-italy-s-lazio-region-b6ff7a9c7111e9f9 2026-09-18T09:09:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-journey-to-self-discovery-the-story-of-a-circle-u-student-fellow-5fea8b858725c8ae 2026-09-18T09:06:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-drugs-and-devices-have-been-on-the-market-for-years-but-fda-ordered-studies-f50b3d6ed1b0bc0d 2026-09-18T09:03:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-specter-of-ai-enabled-bioweapons-is-a-wake-up-call-for-biotech-f0e619b6ad1a6523 2026-09-18T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-marketing-authorisations-granted-in-2026-0fc9c2c1015a12a7 2026-09-18T08:52:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-parallel-import-licences-granted-in-2026-f337a3e18a403d26 2026-09-18T08:52:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/lb-pharmaceuticals-rated-buy-with-85-base-value-150-potential-if-phase-3-succeed-9332fe094c538a69 2026-09-18T08:46:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/mhra-consultation-on-statutory-fees-2026-4e7ecd381fcc9a03 2026-09-18T08:45:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-mnov-36-pbls-10-abcl-9-hae-neo-140ed34b93773a97 2026-09-18T08:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/boehringer-discontinues-phase-iii-easi-kidney-trial-of-vicadrostat-5d694399009054c9 2026-09-18T08:35:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/dimerix-asx-dxb-action3-kidney-disease-trial-remains-central-to-development-path-aa84609d9f537b5b 2026-09-18T08:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hexavalent-combination-vaccine-programme-guidance-83f6b178f952c923 2026-09-18T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/0366002724-ur-test-120ml-sterile-108d430e0a4ba326 2026-09-18T08:14:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/vendanges-sur-le-site-hospitalier-des-hus-de-la-robertsau-pour-les-residents-de-c010efcb07425afd 2026-09-18T08:13:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-guide-to-sarms-definition-side-effects-and-dangers-e67630b4d57afdc1 2026-09-18T08:00:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomedicine-powerhouse-china-targets-quarter-of-global-first-in-class-drugs-6b7e17dcbf9db5c6 2026-09-18T08:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/herzmedizin-und-anatomie-beim-festival-der-wissenschaft-und-neugier-ae5897933fcd4fa9 2026-09-18T07:42:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/bms-dumps-100m-orum-degrader-antibody-conjugate-after-glimpsing-phase-1-data-24ceb75fbe9947ce 2026-09-18T07:41:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-administration-shift-puts-this-corner-of-biotech-back-in-favor-9c761ffe135492bb 2026-09-18T07:28:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-i-keep-going-back-to-ukraine-during-wartime-df612d9b073be5dc 2026-09-18T07:26:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/millimeterarbeit-gegen-lungentumoren-die-music-studie-53be2a6ee6a105b4 2026-09-18T07:14:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/pawbio-animal-health-biologics-services-1a048e6660565241 2026-09-18T07:13:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/tumore-al-seno-in-humanitas-torna-paziente-diplomata-e54455d5d56e61c1 2026-09-18T07:03:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/chronisch-entzundliche-darmerkrankungen-im-fokus-a1687f02fff393f7 2026-09-18T07:03:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-brings-ems-professionals-to-omaha-for-training-4f1f1a30c9c75fcb 2026-09-18T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-medicine-s-alex-zhavoronkov-bets-china-and-ai-can-deliver-the-drug-indu-bf58fc441aef28ac 2026-09-18T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anna-maria-fjordb-ge-discussed-ethnographic-findings-on-digitalisation-and-judic-741ca0d3539fbc98 2026-09-18T06:58:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/inflammation-biotech-electra-charges-up-with-350m-from-upsized-ipo-58f7ac98a3c81cd2 2026-09-18T06:58:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/candidate-christy-knorr-tours-unmc-9c858ca4e9103a33 2026-09-18T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/employee-giving-campaign-runs-through-sept-25-3d755fdad3d90840 2026-09-18T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-klepser-to-lead-session-on-culture-by-design-673f758cb628666c 2026-09-18T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-for-the-record-sept-18-2026-26f128b25ad022fc 2026-09-18T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-leader-shares-insights-on-advancing-healthcare-transformation-across-afric-e197406ab7edc88c 2026-09-18T06:40:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/foundationone-cdx-alk-9df8eafd03eb3fda 2026-09-18T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-obtains-approval-for-foundationone-cdx-cancer-genomic-profile-as-a-compan-a1b0d45f052647e4 2026-09-18T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-and-jolly-good-launch-new-content-for-faceduo-dementia-care-support-vr-un-2392b089dce1c64f 2026-09-18T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fete-de-la-science-2026-b279a061dcc65a5c 2026-09-18T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tissue-repair-asx-trp-phase-3-wound-healing-trial-remains-central-to-development-7287d50919577414 2026-09-18T05:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-unveils-15th-five-year-plan-for-pharmaceutical-industry-targeting-over-20-2ab6174a22012261 2026-09-18T05:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flu-vaccination-in-the-social-care-sector-63cb5603bb33eecd 2026-09-18T05:45:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-latest-iphone-apple-watch-and-airpods-lineups-arrive-in-stores-worldwide-ec905d3774ad7d98 2026-09-18T05:02:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/etra-ipo-news-antibody-biotech-electra-therapeutics-prices-upsized-ipo-at-15-mid-bd92cafd24c85550 2026-09-18T04:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-7-10-15-943b204f7d94498a 2026-09-18T04:57:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/slv-revenue-fell-14-and-net-loss-widened-as-biotech-demand-dropped-but-drug-deve-44b2d4b9fcc80835 2026-09-18T04:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-shares-rise-after-hours-following-fda-approval-ultragenyx-pharmaceuti-4517cfdb85b67294 2026-09-18T04:26:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-restore-a-brain-protein-and-reverse-signs-of-aging-in-mice-e17168fca74ee1f1 2026-09-18T04:25:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/characteristics-of-low-voltage-zones-in-patients-with-heart-failure-with-preserv-5bb4200b0c0df75e 2026-09-18T04:03:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/nitric-oxide-delivery-system-correction-noxbox-updates-use-instructions-for-noxb-a4f02b1fa9701d35 2026-09-18T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ozempic-can-change-your-body-can-it-change-your-life-d702a2323ab8162e 2026-09-18T03:52:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-reddy-s-labs-agrees-to-licensing-deal-with-gilead-for-once-yearly-lenacapavir-c6e21fe407ab9575 2026-09-18T03:38:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-s-olympia-coffee-house-where-christopher-nolan-stopped-for-chai-loses-lic-bb4065e6955e1adc 2026-09-18T03:35:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-safety-crackdown-fda-suspends-licences-of-seven-mumbai-establishments-1bc5a4018c01d902 2026-09-18T03:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innate-pharma-ipha-q2-2026-earnings-call-transcript-2453cef2f5f167e5 2026-09-18T03:07:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/51cc077bbc6c89d0 2026-09-18T03:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-samd-page-updated-guide-revised-seminar-videos-and-materials-published-co-619e30c9b864d6f8 2026-09-18T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-cafe-mondegar-licence-over-food-safety-lapses-wider-crackdown-hits-dbf096ce62824842 2026-09-18T02:46:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/montana-s-new-rules-let-licensed-clinics-sell-drugs-that-cleared-only-phase-1-sa-9e447bd6f824af4e 2026-09-18T02:14:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/feb-19-2026-dhl-group-expands-airfreight-cold-chain-network-to-advance-global-he-b4b7754991d65e96 2026-09-18T02:08:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-shaanxi-panlong-pharmaceutical-group-co-ltd-class-a-stocks-474793fb82a908a6 2026-09-18T02:01:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-21-09-120-anni-della-clinica-mangiagalli-celebriamo-la-culla-d-itali-3c6d6707f48c60b7 2026-09-18T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-ultragenyx-pharmaceutical-rare-reasonable-after-its-fda-gene-therapy-approval-92ee3504e9cb0a80 2026-09-18T01:48:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/bombay-high-court-asks-thane-restaurant-to-approach-food-safety-commissioner-ove-cb94d91d3cc4472d 2026-09-18T01:43:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/simulations-plus-expands-fda-adoption-of-admet-predictor-with-new-licenses-for-t-e883165e7f599585 2026-09-18T01:26:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-amasses-350m-in-biotech-s-latest-big-ipo-978099deecfc2361 2026-09-18T01:16:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-astrazeneca-s-new-breast-cancer-drug-etracama-to-enter-korea-4a59ef93e0c56fb3 2026-09-18T00:50:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-tucsco-10-6-c99883a9f629ce01 2026-09-18T00:43:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-s-350m-ipo-will-help-it-become-a-commercial-biotech-64654e6782d6b4d8 2026-09-18T00:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-therapeutics-announces-pricing-of-upsized-350-0-million-initial-public-o-5224881caefa3cfa 2026-09-18T00:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/area-biotech-looks-ahead-7f2eaf55a0c8b74a 2026-09-18T00:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-retail-investors-buy-68-3b-won-in-sejong-medical-c5ee1465e913cc8f 2026-09-18T00:14:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-dd6239a9df91643d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-universal-visual-foundation-model-for-computational-cytopathology-d4d82831813740f5 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serotonin-neurons-in-the-dorsal-raphe-control-food-craving-like-behavior-during-9b1cc1d30ce78bfd 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reciprocal-connections-dynamically-build-consensus-between-neocortical-areas-2904d1c3185e72a1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-parallel-neural-ectoderm-progenitors-contribute-to-the-developing-brain-27601ed7284656cc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-expression-of-concern-swi-snf-mutant-cancers-depend-on-catalytic-and-n-fa22820503a0bb23 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-genes-shape-personality-and-experience-8e6ff560799a1d26 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chinese-companies-doubled-down-on-science-after-us-tech-restrictions-f5dc675196375a6e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-for-rna-therapy-man-with-rare-motor-neuron-disease-improves-after-treatmen-39d5d7d56656617a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-pushes-for-space-independence-amid-geopolitical-rifts-2bcc4551592c59fc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cognitive-resilience-helps-to-predict-alzheimer-s-dementia-61ec2e4b02e7618b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-research-funding-took-me-out-of-the-lab-and-into-leadership-b04ee2454e589d00 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-myostatin-targeted-antibody-approved-for-spinal-muscular-atrophy-2956859569b7854d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-value-of-speed-for-drug-developers-1de79cdc9775c318 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-99468576d4475ecd 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9794-4-crore-consolidated-revenue-and-e2-82-b9206-5-crore-o-0cd044981af5ad1f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-8dd79c3a6f6e87ed 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-olaparib-tablets-from-the-united-states-fo-62516a983397efc4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-37d5d8d5c2c18251 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-gets-approval-from-its-board-of-directors-for-increasing-it-24ca4672ffc8689d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-completes-acquisition-of-additional-13-25-stake-in-adcock-i-2c167272dd414ca5 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-01f8759d83e0ece0 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-announces-conclusion-of-us-fda-inspection-at-visakhapatnam-3c0ef826ba0e428b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-089df69bf082a363 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-26a72c8773f961bf 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-30139f173ab191c4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investment-of-us-14-million-in-egenesis-inc-by-natco-pharma-canada-inc-and-natco-4daed0de11c9d6a0 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-page-626670b9461fce6d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-vaccine-injury-compensation-program-list-of-petitions-received-6091ed1340d56d14 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electronic-submission-template-for-medical-device-premarket-approval-application-84868d5f9c7d515f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-forms-undergoing-paperwork-reduction-act-review-604ead149a445115 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biosimilar-user-fee-act-iii-future-needs-in-the-development-of-interchangeable-p-fe5a68d526ec88a9 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-of-allergy-and-infectious-diseases-amended-notice-of-meeting-dcb583623cf5f6f4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-post-award-reporting-requirements-inc-48f728e96892f8f4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-phs-applications-and-pre-award-report-45801451bb9edd47 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-delta-region-community-health-systems-development-8a467900dbe269e1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthy-start-self-measured-blood-pressure-monitoring-9a807fe7b2052867 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/infant-toddler-court-program-national-resource-center-87bdf4a836c3d8db 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/target-animal-safety-evaluation-for-veterinary-monoclonal-antibody-products-draf-c6d6364c139b35de 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-library-of-medicine-notice-of-partially-closed-meeting-4cae51d99da667c3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-3df8df59fcecf4b6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-center-for-advancing-translational-sciences-amended-notice-of-meeting-ce1fbb114382a049 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-national-rural-health-policy-community-and-collab-d1edde2289a9483f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-national-rural-health-information-clearinghouse-p-80273b101abb5b18 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-rural-residency-planning-and-development-technica-bad78a3fbc8146b7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vill-forbattra-varden-vid-kronisk-njursjukdom-da50b1e1d961632c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/han-breddar-sin-traumaforskning-med-stod-fran-forskar-at-48a89c1bf1f7d034 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erc-utmarkelse-for-allmanhetens-engagemang-kring-beroring-och-kittlighet-ad92c23fe3cf202f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cascade-watch-a-quality-improvement-approach-to-identifying-and-mitigating-presc-5e4c9b87f73175ce 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacists-perspectives-on-generative-artificial-intelligence-tools-in-pharmacy-9364bf8b6a1b9432 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pill-splitting-for-sustainability-reducing-the-cost-and-environmental-impact-of-e1421773d0d87402 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/practice-tips-for-successful-point-of-care-testing-programs-in-pharmacies-a53ecfbdb2e94510 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-artificial-intelligence-across-the-cancer-drug-discovery-pipeline-us-d7efd9830701ac32 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaco-multiomics-in-major-depressive-disorder-a-narrative-review-and-proposed-42e75faf60364346 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factors-associated-with-clinical-research-participation-among-medicare-beneficia-b7de054f5c62fdeb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-benchmarking-to-global-leadership-singapore-s-health-sciences-authority-s-j-c9dff2d33578c9dd 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-narrative-review-of-emerging-chemoprotective-agents-for-chemotherapy-induced-t-0a67f03191c1e550 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-trial-landscape-of-bispecific-antibodies-in-non-small-cell-lung-can-bcb034023b34aa44 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-systems-microbiology-framework-for-reproducible-multi-dataset-omics-integratio-b779bce51648b197 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-traditional-chinese-medicine-to-enhance-the-efficacy-and-reduce-toxici-f47001b561f23943 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bibliometric-and-clinical-trial-landscape-of-hepatoblastoma-2000-2024-a-multi-da-82994bbd094b43d4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/method-development-validation-and-estimation-of-single-synthetic-drug-tafamidis-6c0d9c088549a9f2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-patient-reported-outcomes-in-non-english-speaking-patients-undergoi-ac4dc44140853a67 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bacteriological-quality-of-pharmaceutical-effluents-in-awka-nigeria-37de73039abf6f90 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-and-safety-of-screening-colonoscopy-in-adults-aged-75-years-and-ol-6d12f15e1391ea8c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-curcumin-in-neurogenesis-and-neuroprotection-in-alzheimer-s-disease-4243af857122205a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opioid-management-for-the-primary-care-physician-a-practical-guideline-based-cli-170f2da712920c3f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanocarriers-for-targeted-drug-delivery-in-cancer-therapy-innovations-and-challe-1c2dc318af7f590f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dual-attention-ensemble-residual-learning-for-robust-diabetic-retinopathy-classi-633f8b4a39b678e6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hand-function-and-oral-hygiene-performance-among-children-with-down-syndrome-a-c-ede1867ad511fb59 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dynamics-and-structure-of-criminal-offenses-related-to-illicit-drug-trafficking-27b75901169137cf 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/applying-the-american-school-counselor-association-asca-ethical-and-legal-standa-8dcb561e1a538c12 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-cardiopulmonary-bypass-duration-on-intensive-care-and-hospital-length-15f8968488fed16d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-retrograde-autologous-priming-on-hematocrit-trajectory-and-transfu-5d9c48524efc7152 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aquagenic-palmoplantar-keratoderma-clinical-histopathological-and-ultrastructura-f28fff81510d6c3b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/combination-therapy-of-biologic-and-non-biologic-systemic-agents-in-psoriasis-a-eb16a4d585839d3a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-neurological-burden-of-cirrhosis-a-comprehensive-clinical-review-of-mechanis-387c5cf15a238ed8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xinshuaifang-improves-oxidative-stress-injury-and-myocardial-remodeling-in-acute-ea34efe2d9af33f7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dencichine-ameliorates-hepatic-fibrosis-by-modulating-the-pi3k-akt-signaling-pat-1feafa88df28df14 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bmscs-promote-apoptosis-in-glioma-cells-by-inhibiting-stat3-phosphorylation-b0ab18bf9d391818 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-report-clinical-and-magnetic-resonance-imaging-findings-in-intracranial-hem-0c206b485101e9e9 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-for-sleep-disordered-breathing-a-taxonomy-of-methods-dat-4212fb2e9998d4f0 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/appropriateness-of-antibiotic-prescribing-in-dental-practice-results-of-two-clin-9e717dd8a6e0113d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-effects-of-digital-literacy-training-on-college-students-self-lead-bc9eb38a15681b18 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanism-aware-and-safety-validated-ai-for-drug-repurposing-a-critical-review-a-fe666815e2b4145a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/temporal-and-clinical-heterogeneity-of-double-m-protein-multiple-myeloma-diagnos-c674cc6b45f5fa7f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/managing-skin-related-adverse-events-during-mirdametinib-treatment-for-nf1-pns-e-9244fb4fa5c44f88 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-landscape-of-bladder-cancer-treatment-a-brief-report-on-new-develop-2a53d6280762f04b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-antenatal-breast-milk-expression-or-postnatal-dietary-intervention-on-8cf881177dc218d1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-protocol-for-a-randomized-controlled-trial-comparing-penetrating-needling-1ca63ddbb2ae5d59 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sacituzumab-govitecan-in-metastatic-breast-cancer-a-systematic-review-and-meta-a-9e64e28209a31e7b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spatial-multi-omics-guided-drug-development-in-inflammatory-bowel-disease-from-m-9d2a193694c20310 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multidimensional-efficacy-characterization-of-xeligekimab-in-moderate-to-severe-54a1dbdb991fe995 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-metabolic-links-between-hypothyroidism-and-metabolic-syndrome-a-rev-26b2ca25872be00b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-guideline-compliant-prescriptions-of-benzodiazepines-and-z-drugs-effects-of-c82e1f698d7a330b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-and-early-predictors-of-metabolic-syndrome-among-adolescents-0979e56242690ce4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-rare-case-report-of-lateral-periodontal-cyst-86813d462bd1795c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/soluble-urokinase-type-plasminogen-activator-receptor-in-glomerular-disease-a-ma-e62ed0c5b157c549 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-flow-nasal-cannula-in-adult-acute-care-physiological-mechanisms-clinical-ev-8f7e270a8cc693dc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxford-nanopore-based-genomic-characterization-of-macrolide-resistance-in-clinic-b0635c7940c6e532 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nucleic-acids-in-medicinal-plants-and-their-pharmaceutical-potential-5a69fb06fb585d6a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-value-of-urinary-albumin-creatinine-ratio-in-predicting-vision-threat-11c3ec9b9f2d15fc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/visual-and-accommodative-outcomes-after-femtosecond-lasik-with-and-without-monov-8f815f409c403df3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-manual-diaphragmatic-release-technique-on-exercise-capacity-and-sleep-a526395573a1476f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/collaborative-clinical-research-ethics-and-regulatory-governance-in-sub-saharan-a80d218f6a293c6d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/saikosaponin-d-ameliorates-non-alcoholic-steatohepatitis-by-inhibiting-sting-med-d926f3f53f604836 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pubertal-delay-in-patients-with-paternally-derived-15q11-2-q13-duplication-syndr-97e9e561d7acd17b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/degradation-of-pharmaceutical-pollutants-in-wastewater-via-cellulose-microsphere-8720e55e1d533a4b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-driven-wearable-gadgets-for-personalization-of-drug-therapy-in-human-and-vete-ad56ba1a0ef26dd0 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leveraging-community-health-workers-for-the-promotion-of-breast-cancer-awareness-755600d79ec1f2d3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-telerehabilitation-based-exercise-and-monitoring-program-and-it-be132e0c48930f0a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-novel-covalent-cdk7-inhibitor-potently-induces-apoptosis-in-acute-mye-92e394580899b083 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/differentiable-latent-structure-discovery-for-interpretable-forecasting-in-clini-0cd199136d6e8b1f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/practice-variation-in-hospital-care-for-pelvic-organ-prolapse-and-urinary-incont-3d823e631c47eefe 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-financial-correlates-of-suicide-attempts-among-patients-with-gambli-02d0125d246d53ed 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-of-childhood-systemic-lupus-erythematosus-complicated-b-7f3038027461f1c3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomized-phase-iii-trial-with-a-factorial-design-assessing-the-efficacy-and-sa-7ec071caeffd2817 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-induced-phospholipidosis-following-haematopoietic-stem-cell-transplantation-ab9302e7e11d6b1d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-combined-hepatic-arterial-infusion-chemotherapy-with-target-ff41a7de4710bf07 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ludwig-s-angina-in-somalia-clinical-characteristics-emergency-management-and-out-db48f21f0e692542 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/powered-by-curiosity-the-emerge-model-for-advancing-clinical-research-leadership-97ddb4d925def0ac 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-survivorship-of-transfibular-trabecular-metal-total-ankle-arthroplasty-045567ef15fb6238 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-term-effects-of-radial-extracorporeal-shock-wave-therapy-in-addition-to-ph-7f21e74b24247cd4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ensuring-x-ray-safety-in-merowe-sudan-78999d828fcc67c9 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nomenclature-standardization-and-health-care-technology-management-0fd3438ec1bfdb35 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peri-plate-gas-detected-on-cervical-ct-as-an-exploratory-imaging-indicator-of-es-d84e1111a3a9cba7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/general-dermatology-and-dermatology-in-primary-health-care-3ec6d2b585374c21 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-acneiform-eruption-with-deucravacitinib-systematic-review-and-meta-an-8a8d04909efec9c9 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determinants-of-community-pharmacists-intention-to-provide-pharmacist-driven-vac-e1abbf554c80558c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecologically-inspired-green-walls-addressing-structural-and-biological-barriers-6db5246f66fa54fb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-and-associated-factors-of-cognitive-impairment-in-patients-with-major-9ec172616c914ae2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognizing-paediatric-ocular-rosacea-clinical-spectrum-diagnostic-clues-and-tre-aa7a7e67addf65f1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-transcutaneous-auricular-vagus-nerve-stimulation-on-postoperative-gast-b4866bdcf6032b2f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/worried-but-not-intending-when-expressive-suppression-dampens-the-motivational-r-bc40ea7445eb3ada 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/crispr-based-mediated-reactivation-of-fetal-hemoglobin-as-a-therapeutic-strategy-ba092edcd3d852ce 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-actionable-biomarkers-in-psychiatry-a-collaborative-roadmap-for-precision-bf1ceccfe95ee9d2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-in-the-bottle-regulatory-insights-on-genetically-modified-microorganisms-1653567a20408884 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transitional-atrioventricular-septal-defect-diagnostic-variability-and-its-clini-29af8aaaec811944 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-comprehensive-review-of-the-phytochemistry-pharmacological-activities-and-clin-ed40f39cb8e477e4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-hybrid-bilstm-transformer-model-for-drug-synergy-prediction-f1cf6f42f7410d30 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-metabolic-epigenetic-axis-in-cardiovascular-disease-acylation-modifications-a9f5a8adcdf04488 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concentration-to-dose-ratio-differences-between-once-daily-tacrolimus-formulatio-c6d84cc0da0ba231 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-expert-consensus-on-the-clinical-application-of-sulodexide-in-vascula-e5031bffd8f56f9f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/translating-deep-learning-innovations-into-clinical-medical-imaging-practice-eaa12e49e6dd3a61 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factors-associated-with-current-frequent-and-multi-substance-use-among-adult-eve-a28e96d8b4e51e85 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hyperadrenergic-and-neuropathic-features-based-on-clinical-autonomic-testing-in-6c45958fcb4f3502 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heliotropium-indicum-protects-against-estradiol-benzoate-induced-endometrial-hyp-4151ed057f65fcf8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/selenium-nanoparticles-enhanced-testicular-thermoregulatory-mechanisms-by-modula-3fbecd66a2f53d28 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioactive-peptides-in-cancer-and-inflammation-mechanisms-model-systems-and-clini-507b06865a134476 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-images-nasal-type-extranodal-natural-killer-t-cell-lymphoma-mimicking-a-7fe393f29eb26cc7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/commentary-on-canadian-study-on-timing-of-methadone-take-homes-5227cedcaf677bb8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-effectiveness-of-community-based-rehabilitation-for-people-with-schizophren-7f065e1266547228 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07829185-modified-folfirinox-and-pentamidine-in-advanced-and-metastatic-pancr-78fa3add49b7bb72 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828626-benefits-of-retained-insulin-for-good-health-e0b0dd20ad9f57c0 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828613-accelerated-flap-coverage-versus-standard-timing-in-the-treatment-of-acf8dea393ecdeb1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828587-effects-of-orofascial-myofunctional-therapy-and-cervical-stabilizati-b01c7ef45f20a1eb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828379-post-market-active-surveillance-and-health-economic-evaluation-of-ce-ea4b9a41fb3ab625 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828314-patient-priorities-in-the-management-of-early-oesophageal-cancer-a-d-c1c5d07e8d45cb6f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828236-phase-1-trial-of-lm-llo-tt-and-gemcitabine-in-unresectable-pancreati-14e0f1e100ed9769 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828223-cardiac-improvement-by-eplerenone-among-patients-under-cyclosporine-15c1ebccbe3914a8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828210-neuroaid-patient-reported-outcomes-in-patients-with-mild-to-moderate-aebf40e5cadccc25 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828080-clinical-outcomes-of-primary-cementless-total-hip-arthroplasty-using-b8092242ac89b7ab 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828067-short-versus-standard-dental-implants-clinical-and-biomarker-outcome-7d7695cddc772f99 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827833-clinical-performance-and-failure-rates-of-restorations-following-ped-5c6076eaa01acf7a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827573-a-study-to-learn-how-well-participants-with-a-specific-type-of-early-8265b1ae972fd33e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827326-clinical-utility-of-needle-based-confocal-laser-endomicroscopy-for-p-68c540e9ca7775bb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827170-bacillus-probiotics-with-bismuth-quadruple-therapy-for-helicobacter-4694cb3f6bb3e8b8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827144-a-study-to-test-how-well-different-doses-of-bi-4060107-are-tolerated-2178f7ba02d8077f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07806916-efficacy-and-safety-of-efgartigimod-in-the-treatment-of-guillain-bar-f67ec03dd482061e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07743476-bone-marrow-imaging-and-clinical-outcomes-across-hematologic-oncolog-e022df71fdff851f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07683104-natural-history-of-trisomy-8-associated-autoinflammatory-disease-tri-a10b26c09d1352ed 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07617337-aqua07-in-patients-with-alk-positive-non-small-cell-lung-cancer-9575a10c54b83efb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07585968-safety-and-effectiveness-of-the-sphere-9tm-catheter-and-afferatm-abl-6e22d8fa3f907fc6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07576452-first-lines-of-biologics-in-patients-with-ulcerative-colitis-a-rando-6f24cff714c98475 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07567833-longitudinal-study-of-retinal-function-in-eyes-treated-for-diabetic-81b93e4ee1654505 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07520383-nanopulse-laser-therapy-266285f6b1cfdf8f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07472049-symptomatic-and-systemic-atherosclerotic-plaque-activity-in-patients-2655d0dda387168f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07224152-nbtxr3-with-radiation-therapy-alone-for-locally-advanced-non-small-c-3d8d0ac6f10837d7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07204964-a-study-to-evaluate-the-immune-response-and-safety-of-an-influenza-v-a165910ebe79d288 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07181109-zilebesiran-in-patients-with-hypertension-not-adequately-controlled-3cffe79ee8aab051 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07111065-fast-for-dm-fatty-acid-supplementation-trial-fast-for-dermatomyositi-ed2b3f59cab40468 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07047118-a-study-of-jsb462-luxdegalutamide-plus-lutetium-177lu-vipivotide-tet-c964db7ee09b20b1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06948981-gt719-injection-for-the-treatment-of-recurrent-refractory-cd19-posit-dca6471439e80ee7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06888193-a-study-to-assess-the-concentration-of-bimekizumab-in-mature-breast-b55c9f50bb539f7c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06859762-a-first-in-human-study-of-yl217-in-patients-with-advanced-solid-tumo-c4eaace35a78886b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06790784-faricimab-prp-vs-vitrectomy-endolaser-for-treatment-of-pdr-514938e04219b871 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06746688-a-first-in-human-clinical-trial-assessing-the-safety-of-es2b-c001-s0-17414cc8604923e5 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06665646-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-hiltonol-b217282ad3e5577e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06340360-a-phase-2b-study-to-evaluate-rezpegaldesleukin-rezpeg-in-the-treatme-361399e578bce777 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06337318-comparing-rituximab-and-mosunetuzumab-drug-treatments-for-people-wit-f9c0f74dff068b0e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06274749-effects-of-urolithin-a-supplementation-on-glucose-metabolism-in-heal-597167a31fc2a3ba 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06236880-a-phase-2a-study-to-evaluate-the-safety-and-tolerability-of-gm-2505-68ae07b9ae661840 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06208306-a-study-to-investigate-long-term-safety-and-tolerability-of-itepekim-795e6ff774e38b35 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06198712-a-study-to-evaluate-the-pharmacokinetics-and-safety-of-etavopivat-in-89892e79fdf869e6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06140147-protocolized-reduction-of-non-resuscitation-fluids-versus-usual-care-760c20ac150f2923 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06126276-testing-the-use-of-neratinib-or-the-combination-of-neratinib-and-pal-d0a38b42801b4a0e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06058377-adding-an-immunotherapy-drug-medi4736-durvalumab-to-the-usual-chemot-2e48b979fc6c9737 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05863052-analyzing-clinical-outcomes-and-genomic-data-of-american-indian-pati-1bdf5bf93f324809 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05853406-determination-of-a-minimal-clinically-important-difference-of-the-fu-048ead8a89cb979a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05554406-testing-new-therapies-for-patients-with-acute-myeloid-leukemia-who-a-7ba612c389b9cb0e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04291755-development-and-analysis-of-a-stool-bank-for-cancer-patients-794566bc56e70a73 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04248582-cryotherapy-for-locally-advanced-esophageal-cancer-04dd1c30299a7143 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04208178-study-of-alpelisib-byl719-in-combination-with-trastuzumab-and-pertuz-96d9a1e3348be3e2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04127578-phase-1-2a-clinical-trial-of-pr001-ly3884961-in-patients-with-parkin-77b63db4617f76e2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03776487-nivolumab-ipilimumab-and-chemoradiation-in-treating-patients-with-re-51b58236c902783c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03630991-edetate-calcium-disodium-or-succimer-in-treating-patients-with-acute-6989090ed6697ab1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03508752-neurocognitive-decline-in-patients-with-brain-metastases-b33656dd6da1ef6c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02610855-effect-of-treatment-on-activity-and-muscle-function-in-pediatric-pat-baaa89fe2dea3b78 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02579967-pilot-trial-of-allogeneic-blood-or-marrow-transplantation-for-primar-8c7901845d5d7951 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02119611-deep-brain-stimulation-therapy-in-movement-disorders-3557cb2032e18f4f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01035879-study-to-evaluate-the-efficacy-safety-tolerability-and-pharmacokinet-2a57cef36373f475 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-complexities-of-340b-rebate-tracking-345d5ee106e9a4f8 2026-09-17T23:38:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/padcevtm-enfortumab-vedotin-in-combination-with-keytruda-pembrolizumab-receives-8cf462a80b8a5d5c 2026-09-17T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-s-strikes-on-pharmaceutical-warehouses-threaten-ukrainians-access-to-medi-1481cd7f4bb09f30 2026-09-17T23:10:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-biotech-companies-pitch-at-5th-annual-biodiscovery-summit-685693dd844a95e0 2026-09-17T23:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-oral-drug-indicated-to-treat-dermatomyositis-in-adults-64759fb9feb9d221 2026-09-17T22:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-map-hidden-protein-network-that-helps-red-blood-cells-adapt-to-oxygen-7afbbb0fc95ddfd1 2026-09-17T22:07:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/icb-homenageia-luiz-eurico-nasciutti-e-da-nome-do-professor-a-auditorio-7e639652208cc3c8 2026-09-17T22:06:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/these-biotech-stocks-are-cheap-based-on-1-fundamental-measure-815f0f905b0e25d8 2026-09-17T21:53:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/convergence-eu-officials-tout-pending-pharmaceutical-reforms-7ec250273dd2050a 2026-09-17T21:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-regulators-urge-more-research-on-testosterone-therapy-for-women-as-experts-de-80bb0693f610f163 2026-09-17T21:20:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-commemoration-of-world-patient-safety-day-novo-indonesia-invites-the-communit-c729bf0bf9594fa9 2026-09-17T21:18:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-0a2c211f558a4086 2026-09-17T21:17:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/israeli-ag-biotech-firm-sets-up-north-american-hq-in-indiana-e82697c880a79273 2026-09-17T21:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-use-patient-feedback-in-clinical-trial-design-7307a00bb66a4178 2026-09-17T20:55:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-ultragenyx-s-gene-therapy-fayuvi-for-rare-neurodegenerative-disorde-3a99a3afac6a189b 2026-09-17T20:50:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pharmaceutical-industry-has-seven-years-to-solve-a-12-digit-problem-2ce095089f5a385f 2026-09-17T20:36:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-emitio-carta-de-cierre-por-la-subsanacion-de-los-incumplimientos-detectado-5e048f3571d027fb 2026-09-17T20:21:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/recon-senate-hearing-set-for-fda-nominee-novo-partners-with-anthropic-for-ai-dru-74e2264d9dcc1de7 2026-09-17T20:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-kidney-drug-cut-teens-urine-protein-by-75-versus-placebo-1fc57cd2c9a56347 2026-09-17T20:18:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-pediatric-empaveli-data-published-in-clinical-journal-of-the-american-so-5091818a62b05fe0 2026-09-17T20:18:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-announces-azetukalner-nda-submission-to-fda-for-focal-seizures-and-provide-037241532935d25e 2026-09-17T20:17:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-pediatric-empaveli-data-published-in-clinical-journal-of-the-american-so-18c673b3e90bf413 2026-09-17T20:16:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-shrinking-return-on-investment-for-nordic-innovation-1ab4bf8551082130 2026-09-17T20:09:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/carolina-to-celebrate-america-250-through-poetry-performances-discussions-and-mo-0887df79ba556182 2026-09-17T20:06:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-submits-a-seizure-drug-to-fda-while-pausing-new-depression-trial-enrollmen-ed814c8e3c5c404e 2026-09-17T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-ltd-nasdaq-blrx-share-price-blrx-stock-news-blrx-share-price-updates-7f60262f5eff496b 2026-09-17T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/goa-therapeutics-emerges-from-stealth-with-15-5-million-in-funding-and-unveils-g-4c38cf3c6f2869ef 2026-09-17T19:57:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-biotech-companies-pitch-at-5th-annual-biodiscovery-summit-bf6d2c55316ea44d 2026-09-17T19:49:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-new-indication-for-kerendia-pharmexec-6d2c25c3e5f2cd54 2026-09-17T19:45:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-bi-weekly-new-multiplex-immunofluorescence-tool-a-human-genome-datab-a5d3e08006cbc4b2 2026-09-17T19:39:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-gene-therapy-for-pediatric-patients-with-sanfilippo-syndrome-4b753211a5d929e8 2026-09-17T19:37:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-pharmaceutical-packaging-trends-to-know-a8bfd26f9dca5759 2026-09-17T19:33:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/17-09-il-policlinico-di-milano-si-illumina-di-arancione-per-la-giornata-nazional-4a1539b5441c3634 2026-09-17T19:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/construction-industry-champions-heart-health-through-campaign-169f417446778731 2026-09-17T19:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-and-utah-highway-safety-office-urge-parents-to-rethink-comm-8067c480bdd51a75 2026-09-17T19:14:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-takeda-s-orzeyful-as-first-drug-to-treat-narcolepsy-type-1-cause-49d3fb93ffe19a13 2026-09-17T18:43:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-announces-grand-opening-of-its-innovation-center-boston-to-drive-advanceme-f51da51b1bf34aa9 2026-09-17T18:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-realities-of-china-s-prolific-biotech-rise-are-felt-at-fda-1795c883b63f206a 2026-09-17T18:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-biotech-framework-uses-ai-scientists-to-pursue-probe-drug-discovery-19244671a207ef09 2026-09-17T18:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wegovy-for-children-under-12-sparks-obesity-debate-67a99e0bdea0cb68 2026-09-17T18:15:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/live-from-dc-can-the-fda-steer-clinical-trials-back-to-the-us-post-hoc-live-25792fcad212d192 2026-09-17T18:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/stricter-fda-norms-cast-shadow-on-ganesh-mandals-mahaprasad-plans-only-250-enrol-2c7c8c07d156ef63 2026-09-17T18:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-biotech-company-puts-thousands-of-ai-scientist-agents-to-work-on-drug-di-723a870ca063cacd 2026-09-17T18:04:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-begins-phase-1-clinical-trial-of-ebola-vaccine-against-strain-behind-drc-0f15edae8af6e558 2026-09-17T17:51:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerated-research-increased-investment-signal-landmark-year-for-food-is-medic-037665fb995f5136 2026-09-17T17:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transferencia-a-municipios-facultad-de-ciencias-exactas-25750730448c9187 2026-09-17T17:29:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/iqhq-hands-vacant-biotech-building-back-to-lender-as-bay-area-life-sciences-slum-4369a9fe64919d18 2026-09-17T17:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-tak-gets-priority-review-can-zasocitinib-win-in-psoriasis-3598469b22effd81 2026-09-17T17:08:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/maryland-makes-its-case-as-a-model-for-u-s-biotech-supply-chain-security-3ddb3271125dc205 2026-09-17T16:57:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/frances-oldham-kelsey-the-pharmacologist-who-stopped-thalidomide-73c1c740e2953127 2026-09-17T16:52:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-novo-nordisk-stock-trading-higher-today-novo-nordisk-nyse-nvo-146fc47e146018ac 2026-09-17T16:44:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/altis-labs-raises-us-25-million-series-a-co-led-by-orbimed-to-accelerate-clinica-938f7b0684c81129 2026-09-17T16:44:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial-b2b5a50b508a6418 2026-09-17T16:39:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-eases-compounding-rules-for-preemie-nutrition-packs-as-supply-shortage-looms-8798c0cbcd5cf433 2026-09-17T16:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ideaya-biosciences-stock-gains-attention-as-ide-849-moves-toward-phase-3-d8645ee5bb43994f 2026-09-17T16:33:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-much-does-a-tms-machine-cost-pricing-and-total-cost-of-ownership-compared-fo-4d06c42d3d7ea456 2026-09-17T16:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/unc-health-school-of-medicine-leaders-build-connections-in-ireland-b835479b32f4a15a 2026-09-17T16:29:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-biotech-company-had-268-million-in-cash-after-a-failed-drug-trial-it-announced-f6d2b2fc48d86112 2026-09-17T16:19:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/marlaina-goedel-marks-two-years-insulin-free-after-becoming-the-first-patient-in-c146a8c3d88155c5 2026-09-17T16:19:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-eledon-s-push-to-transform-type-1-diabetes-care-78d5e3a63d6b0ed6 2026-09-17T16:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eu-joint-clinical-assessment-turning-hta-reform-into-a-market-access-advanta-dd9e756bfa433d56 2026-09-17T16:14:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-immunology-joins-biotech-reverse-merger-boom-with-aethlon-deal-b8f9ff2d896dff1e 2026-09-17T16:09:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-snda-for-taletrectinib-in-ros1-nsclc-53ff6cb7f80eb90a 2026-09-17T16:07:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-diagnoses-a-major-factor-in-allina-health-s-doctors-strike-23be44412a8b9da9 2026-09-17T15:56:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-challengers-why-it-will-be-hard-in-a-midterm-likely-to-herald-change-to-oust-97f56f6d2eef548e 2026-09-17T15:55:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-minnesota-s-sentencing-guidelines-why-fraud-cases-rarely-lead-to-prison-68d9f5fccba4cc1a 2026-09-17T15:55:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-your-health-vaccine-recommendations-091737b5dba58c68 2026-09-17T15:54:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/northern-soy-marketing-welcoming-southeast-asian-soy-buyers-for-fourth-annual-cr-0f93f965c70c1661 2026-09-17T15:54:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/students-explore-hmong-culture-through-gardening-program-483fe2ab61b687c4 2026-09-17T15:53:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/days-after-maharashtra-fda-revelation-medicine-safety-act-sought-to-prevent-expl-62dece922f3831a3 2026-09-17T15:34:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-inside-the-ndc-12-transition-f8240ebebcaa2280 2026-09-17T15:34:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/there-s-a-biotech-stock-on-josh-brown-s-list-that-s-ignoring-the-market-noise-an-00acfc4984bf14ef 2026-09-17T15:32:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-mechanism-discovered-that-helps-cells-prevent-errors-during-dna-replicatio-799e041dbb008041 2026-09-17T15:25:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/moving-forward-with-purpose-77635de00e54261e 2026-09-17T15:15:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-rochester-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-he-83ecf322ceaf42b9 2026-09-17T15:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-es-du-chu-vos-factures-et-leur-mode-de-transmission-evoluent-4dc4dbcbdd7a58d6 2026-09-17T15:01:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/retour-sur-le-1eseminaire-prevenir-dedie-aux-professionnel-les-du-chu-2e56edc628cd51e6 2026-09-17T14:55:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-to-present-phase-3-etentamig-results-and-data-from-broad-multiple-myeloma-29444dd186815626 2026-09-17T14:53:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-maryland-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-hea-ad7cc39c4825b3a6 2026-09-17T14:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/classement-newsweek-gustave-roussy-premier-centre-de-lutte-contre-le-cancer-en-e-4e1ce4ca95c94eb3 2026-09-17T14:52:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/becas-internacionales-de-la-subsecretaria-de-relaciones-internacionales-e-interj-dfa8f436132d68d8 2026-09-17T14:45:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-escalator-legend-biotech-biomarin-turn-therapeutics-and-more-59a1bb9970ad70be 2026-09-17T14:43:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-popular-fermented-food-may-help-flush-nanoplastics-from-the-body-95f0ba92fb6fd6eb 2026-09-17T14:42:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/southern-virginia-heart-walk-brings-community-businesses-together-to-fight-heart-f5b148de4b03b26b 2026-09-17T14:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-named-to-time-s-world-s-top-healthtech-companies-for-the-second-c-9311e95b20857983 2026-09-17T14:35:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-opens-grand-junction-physical-therapy-clinic-b0291a44cc83f8fa 2026-09-17T14:34:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/centanafadine-may-offer-second-line-option-for-patients-with-adhd-if-stimulants-3e160ac2fc5ea8b2 2026-09-17T14:34:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-startup-to-test-psychedelic-like-drug-against-parkinson-s-symptom-b4ed51ead7a85a49 2026-09-17T14:34:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/5th-circuit-panel-seems-skeptical-of-louisiana-abortion-pill-case-aa9c158dc8721073 2026-09-17T14:32:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/measuring-excess-mortality-a-guide-to-the-main-reports-12c7784e1f020f77 2026-09-17T14:31:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-consequence-infectious-disease-country-specific-risk-11ed7e663ad962ce 2026-09-17T14:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-and-marburg-haemorrhagic-fevers-outbreaks-and-case-locations-16b29cdb0bb31831 2026-09-17T14:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/outbreaks-under-monitoring-in-2026-eb6ae222898106b1 2026-09-17T14:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiac-arrest-survivors-sisters-advocate-for-health-and-raise-funds-critical-fo-88a18b7d57821017 2026-09-17T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuer-biodrucker-fur-die-plastisch-und-handchirurgische-klinik-7c40774901042ea9 2026-09-17T14:29:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/working-for-dhsc-7fde6c0568507ce7 2026-09-17T14:17:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/creating-value-through-early-phase-trial-design-how-the-fda-s-single-phase-3-piv-990fc2d9ece24c53 2026-09-17T14:15:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/pet-come-si-svolge-l-esame-3a1f061b28f6012b 2026-09-17T14:14:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/usz-erreicht-spitzenplatze-in-elf-fachbereichen-e640f37cd5d6e7b6 2026-09-17T14:12:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-20-september-2026-7353f08bd7424352 2026-09-17T14:09:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-eliminates-outdated-uv-filters-as-regulatory-modernization-continues-2732866e9bc52a42 2026-09-17T14:09:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/aquestive-resubmits-nda-for-sublingual-epinephrine-film-anaphylm-after-fda-crl-cbe278ad7206f20a 2026-09-17T14:05:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-company-receives-second-grant-to-develop-gene-therapy-for-afib-8bff45b3daa50406 2026-09-17T14:03:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelic-definium-s-lsd-based-drug-meets-endpoints-in-gad-study-9946f77790c4ebaf 2026-09-17T14:02:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/minister-of-state-for-social-care-and-mental-health-speech-on-dementia-4b19c9af5602321d 2026-09-17T14:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-puget-sound-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-228ecfcb192837c8 2026-09-17T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quand-l-ia-remet-en-question-la-prise-en-charge-des-victimes-d-infarctus-du-myoc-5d9e791bbdde1e14 2026-09-17T13:57:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-powered-radiology-saves-lives-european-commission-president-von-der-leyen-hig-2fafb3df665b5695 2026-09-17T13:57:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fed-rate-hike-won-t-hold-biotech-down-despite-climbing-capital-costs-f2607a72bd40fecd 2026-09-17T13:43:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-novartis-devastating-m-a-losses-long-live-the-executive-willing-to-try-1e02e33acfc9b6f0 2026-09-17T13:39:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacy-researcher-develops-treatment-for-mosquito-borne-virus-378d3039ffeae71a 2026-09-17T13:38:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/altis-labs-ai-imaging-endpoint-predicts-overall-survival-benefit-in-phase-3-lung-bd3f1bdba2973e05 2026-09-17T13:37:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-central-virginia-leaders-advocate-for-health-and-raise-funds-critical-for-figh-1385cc8b03f49fd4 2026-09-17T13:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-raises-123-million-series-c-to-advance-oral-thyroid-eye-disea-ce33343ebad3dfb2 2026-09-17T13:30:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-ibtrozi-for-locally-advanced-or-metastatic-ros1-nsclc-41cf331ea6cf4701 2026-09-17T13:23:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-discovery-stock-up-50-in-1-year-why-it-rallied-f7e3a6bd438b8317 2026-09-17T13:22:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-biotech-ipo-prospects-testing-investor-appetite-2e6e9f9857fd271b 2026-09-17T13:21:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-un-error-en-el-etiquetado-de-las-protesis-vasculares-silver-c6caa0a9382e566d 2026-09-17T13:19:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/chair-appointed-to-lead-tees-esk-and-wear-valleys-trust-inquiry-242a5861e8dd65d0 2026-09-17T13:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abclon-global-phase-3-trial-for-ac101-to-wrap-in-2027-dual-targeting-adc-trials-807ffe3f89f9a483 2026-09-17T13:01:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-2026-to-2027-46b78a2386536090 2026-09-17T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/syndromic-surveillance-weekly-summaries-for-2026-45747e3878253def 2026-09-17T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/remote-health-advice-weekly-bulletins-for-2026-0b8fbceac342c05c 2026-09-17T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-ambulance-syndromic-surveillance-weekly-bulletins-2026-6dee157afd1fba75 2026-09-17T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/gp-out-of-hours-syndromic-surveillance-weekly-bulletins-for-2026-f212a5a75078c06e 2026-09-17T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/gp-in-hours-weekly-bulletins-for-2026-dfebf391f225843d 2026-09-17T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergency-department-weekly-bulletins-for-2026-08abcdde2881ef86 2026-09-17T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-greater-washington-region-leaders-advocate-for-health-and-raise-funds-crit-e169275d47aa7823 2026-09-17T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/6-san-diego-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-he-07e6369e95026acc 2026-09-17T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-orange-county-leaders-advocate-for-health-and-raise-funds-critical-for-fightin-ac3fdca06ad0aac4 2026-09-17T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiofrequency-rf-safety-considerations-for-wireless-cardiotocography-ctg-monito-ae4383240e38c90d 2026-09-17T12:59:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/creatina-5-0-8ce63b00b277d512 2026-09-17T12:52:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/editors-picks-september-2026-drug-resistance-breast-cancer-treatment-covid-19-an-ca8bd5ac0be95b61 2026-09-17T12:52:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/jeffrey-barrettin-tavoitteena-on-sairauksien-havaitseminen-aiemmin-ja-tarkemmin-9d7dbbbd15943811 2026-09-17T12:49:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/sol-gel-technologies-announces-last-patient-last-visit-in-pivotal-phase-3-clinic-539ee55d128eb77a 2026-09-17T12:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alumna-preserves-dolly-parton-s-literacy-legacy-statewide-d00d4d503383679c 2026-09-17T12:44:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/cm3-caps-cm3-powder-250g-pink-grapefruit-e200f93ecbd03131 2026-09-17T12:39:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/ea76e3bd2f39dc5b 2026-09-17T12:31:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/sol-gel-technologies-slgl-hits-key-phase-3-gorlin-milestone-29a6a1657afaa450 2026-09-17T12:30:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-patient-safety-day-when-being-disbelieved-becomes-a-patient-safety-issueby-d13b18200dd9ab2f 2026-09-17T12:30:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-skin-cancer-trial-reaches-its-final-visit-sol-gel-expects-results-in-late-nove-265a07288f881304 2026-09-17T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-to-present-phase-3-etentamig-results-and-data-from-broad-multiple-myeloma-3861cacd7165fe8b 2026-09-17T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-finds-irritability-long-after-concussions-in-veterans-is-linked-to-ptsd-ch-8cbe15644c31b9c9 2026-09-17T12:18:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effects-of-financial-incentives-are-often-underestimated-d7d29eb243b4af93 2026-09-17T12:02:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-you-really-shouldn-t-overcook-your-proteins-e42fa4a2df65e838 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-oxalate-reagent-kit-e550250a7b0c93ec 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapicidetm-pa-high-level-disinfectant-bc00a62bf84be4e9 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/philips-ingenia-achieva-and-intera-mr-systems-76648b3b19c78211 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-long-island-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-871326a26c6bc78c 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergan-aesthetics-presents-new-clinical-data-evaluating-skin-quality-improveme-b8a40f46cc9abc67 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/class-4-medicines-defect-notification-martindale-pharmaceuticals-ltd-clobazam-ma-212604759061b3b7 2026-09-17T11:59:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/democrats-pump-and-dump-attacks-against-vivek-ramaswamy-don-t-add-up-da22e8191dbb38b2 2026-09-17T11:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-de-la-noche-de-los-lapices-recuperar-la-historia-para-construir-nuevas-f4b63b1a1ae128a8 2026-09-17T11:47:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fennec-pharmaceuticals-announces-oral-presentation-of-detailed-results-from-inve-e87af58248a92da4 2026-09-17T11:46:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-immunology-goes-public-via-reverse-merger-as-eczema-drug-heads-toward-clin-ac5eaa2ebdb610e1 2026-09-17T11:40:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuvation-bio-announces-fda-approval-of-supplemental-new-drug-application-for-ibt-74142b5856010ab0 2026-09-17T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heidelberger-forschungsprojekt-gibt-ns-opfern-namen-und-geschichte-zuruck-619686dc49c6e31a 2026-09-17T11:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccination-autumn-programme-resources-3e4d4b5a8c8a27bc 2026-09-17T11:14:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-natural-gut-compound-that-helps-heal-the-intestine-70b8ceac267e05a3 2026-09-17T11:13:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergy-film-that-cuts-dosing-time-resubmitted-by-aquestive-nasdaq-aqst-1ba0b5ab1fe3f8d6 2026-09-17T11:03:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-announces-signing-of-mou-with-king-abdullah-international-391b307649c2487b 2026-09-17T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyllene-therapeutics-appoints-seasoned-biotech-executive-dr-marc-grasso-as-chief-b2a33d9a332c8832 2026-09-17T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hovione-pharmaceutical-company-opens-31k-sq-ft-facility-in-east-windsor-adding-a-63b3a40a0c111755 2026-09-17T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-presents-sotyktu-deucravacitinib-data-showing-durable-effic-ab59c6531d46fb79 2026-09-17T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-explores-macrocycles-potential-in-1-4b-cardiometabolic-pact-with-danish-bio-83b246e22760048d 2026-09-17T10:56:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/textbooks-may-have-misdrawn-this-basic-brain-structure-for-100-years-7581a3479b32e04e 2026-09-17T10:54:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/symposium-indigenous-relationships-with-time-47fe510eed976233 2026-09-17T10:46:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/70mg-4ml-962d855db4c60637 2026-09-17T10:35:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-biotech-hedge-fund-births-a-new-immunology-company-81b7beb45c9e906f 2026-09-17T10:34:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/innate-pharma-ipha-extends-cash-runway-to-q1-2028-after-sobi-deal-and-30m-share-356bebb27c4a8704 2026-09-17T10:34:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/recovering-lives-preventing-social-exclusion-six-years-supporting-home-recovery-3bdf027939b055c5 2026-09-17T10:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-ordered-studies-of-many-drugs-devices-on-the-market-are-not-done-86a4a800b65f63b0 2026-09-17T10:32:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/children-s-public-health-nursing-workforce-and-activity-2025-cf1dc915acbdddd5 2026-09-17T10:26:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-reddy-s-enters-royalty-free-agreement-with-gilead-for-annual-lenacapavir-hiv-425716ba2f3f604b 2026-09-17T10:22:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/upfront-cash-hits-innate-pharma-ipha-as-lymphoma-drug-pact-takes-effect-b9face9e737abc29 2026-09-17T10:22:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-companies-prepare-production-in-orbit-channel-newsasia-69453acee50ff8ba 2026-09-17T10:18:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/southnord-artfest-2026-roots-en-route-bee1bb7e9ad69218 2026-09-17T10:10:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/get-the-care-you-need-where-you-need-it-df971658819361e2 2026-09-17T10:08:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-apollo-bc-advanced-perfused-platform-for-breast-cancer-therapy-re-e0b3d1094d7d5a18 2026-09-17T10:03:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-extended-reality-technologies-research-and-training-in-healthcare-09b8df81b2fae8bf 2026-09-17T10:03:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-re-wiring-tumor-immune-evasive-plasticity-with-mrna-therapy-c5d902cadf530a9e 2026-09-17T10:03:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-international-staff-exchange-for-preterm-birth-early-diagnosis-an-ac5c4ef903559990 2026-09-17T10:03:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/testosterone-for-menopausal-women-fda-review-sparks-debate-a4d78420495e25b5 2026-09-17T10:01:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/universite-paris-cite-stands-out-once-again-in-the-2026-shanghai-thematic-rankin-46ce1d0268d638fc 2026-09-17T09:43:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/swiss-company-roche-succeeds-in-phase-3-trial-of-cancer-drug-6ebb3f484a643754 2026-09-17T09:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-be-on-tour-2026-klinische-studies-zijn-een-strategisch-pluspunt-voor-pati-78f02618f856aad7 2026-09-17T09:22:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-has-a-grip-on-america-s-pharmaceutical-industry-and-that-s-a-threat-on-nat-56163250b91fc512 2026-09-17T09:13:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/de-lancering-van-een-concurrentiekrachtbarometer-voor-de-biofarmaceutische-indus-68cf590c40dc0e6d 2026-09-17T09:05:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/life-changing-cancer-treatment-could-transform-care-for-autoimmune-conditions-664000b9a06fd29f 2026-09-17T09:03:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/boehringer-halts-phase-iii-kidney-trial-of-vicadrostat-jardiance-combination-0741a91de32987de 2026-09-17T08:57:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/benchmarking-the-foundation-of-reliable-ai-in-biomedicine-b0c86ba0d683f2e0 2026-09-17T08:56:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/longeveron-s-phase-2b-stem-cell-flop-spurs-cost-cutting-exploration-of-all-optio-5a694be2f452f7d3 2026-09-17T08:44:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-s-fda-overhaul-how-a-food-safety-watchdog-is-now-taking-on-drug-p-223ff0e222293168 2026-09-17T08:33:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/measles-epidemiology-2023-to-2026-1387e9c40489bd37 2026-09-17T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/environmental-monitoring-following-the-grenfell-tower-fire-85d5cc3f2b36adbc 2026-09-17T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/salmonella-outbreak-update-dbba55fa25793323 2026-09-17T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioscience-and-health-technology-sector-statistics-2024-to-2025-76d66d939a9818b2 2026-09-17T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/salmonella-statistical-releases-5659a2d745797007 2026-09-17T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioscience-and-health-technology-sector-statistics-6c8da0610eecb0b8 2026-09-17T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/informationstag-pankreaszysten-wann-ist-eine-behandlung-notwendig-e06e284e6f7f97ef 2026-09-17T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-2026-217279a39fb91d0d 2026-09-17T08:27:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/revolution-medicines-just-hit-a-major-milestone-is-the-stock-a-buy-a1dc82995834a458 2026-09-17T08:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/migrant-health-guide-bdf31ac2db51f874 2026-09-17T08:16:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunisation-patient-group-direction-pgd-templates-1af7ede7c1c283c6 2026-09-17T08:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-connects-with-120-korean-biotechs-in-search-for-r-d-licensing-deals-6032fe94dde44e6f 2026-09-17T07:54:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/ovmedi-s-knee-pain-relief-device-wins-fda-breakthrough-device-designation-f419ab739f1617a4 2026-09-17T07:50:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtu-packaging-cooperation-is-key-b7cc7f88c1ecb9e2 2026-09-17T07:44:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-tiny-biotech-is-beating-mrna-iova-and-sls-here-s-how-a-billionaire-fueled-i-f9fadbaa2502bed3 2026-09-17T07:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/was-einen-starken-forschungsstandort-ausmacht-c7dadc2f0a981335 2026-09-17T07:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/generative-ai-in-research-build-your-confidence-with-the-new-eur-online-module-767063a0e5d287dd 2026-09-17T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taen-b529781628a7a773 2026-09-17T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/school-of-nursing-earns-national-heed-award-for-inclusive-excellence-29847b6adccee306 2026-09-17T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gemeinsam-die-universitatsmedizin-in-bayern-starken-5e2ecb52b4188f5e 2026-09-17T06:59:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/mmi-marks-five-years-in-state-of-the-art-building-50d06298edd2b99c 2026-09-17T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/title-ix-office-begins-new-professional-development-series-ff66984912be811a 2026-09-17T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-ai-drug-development-milestones-land-in-a-single-day-as-novo-nordisk-eli-li-84c7a7e7c962ec5e 2026-09-17T06:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognizing-constitution-day-d98419201ae9733f 2026-09-17T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/akeso-s-lung-cancer-drug-posts-impressive-overall-survival-data-cicc-raises-targ-f61410636fb8d53a 2026-09-17T06:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iii-celestimo-87908e384e7148f6 2026-09-17T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-announces-phase-iii-celestimo-study-results-for-lunsumio-in-relapsed-or-re-a71e89ddbda78c93 2026-09-17T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/israel-national-biotech-innovation-center-inbi-launches-with-anat-cohen-dayag-as-8dca37929128a225 2026-09-17T06:29:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/hong-kong-biotech-stock-roundup-these-are-the-top-performers-in-2026-9150468048a7f3f7 2026-09-17T06:24:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-raids-12-establishments-seizes-food-worth-56-36-lakh-in-festive-food-sa-814c0d81f0358e5e 2026-09-17T06:18:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-price-today-teva-pharmaceutical-industries-limited-stock-price-quote-chart-8ccacc4f83865af8 2026-09-17T06:03:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-startet-zentrale-ki-plattform-fur-klinik-forschung-lehre-und-verwaltung-89e5b497a98fecf5 2026-09-17T06:02:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/patienternas-erfarenheter-hjalper-varden-att-bli-sakrare-2fd987b01dd45f54 2026-09-17T06:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellules-familiales-c-est-quoi-le-microchimerisme-8a5315b67884f4dc 2026-09-17T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-genscript-biotech-stock-surging-today-cfcf0dd9005195ab 2026-09-17T05:58:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-6-10-16-eadf968f3e2a6944 2026-09-17T05:22:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-genscript-biotech-stock-surging-today-by-investing-com-e81c2f3bca3a32c8 2026-09-17T05:12:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-mesothelioma-drug-turns-cancer-s-own-defenses-against-it-d5f48e25cd3a7e54 2026-09-17T05:11:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-lunsumio-based-regimen-significantly-improves-progression-free-survival-a306a35baacb9b1f 2026-09-17T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/basic-earnings-per-share-basic-eps-of-gin-hwa-biotech-inc-tpex-7806-f0510930868fe55c 2026-09-17T04:30:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/tailoring-the-atrioventricular-interval-during-left-bundle-branch-pacing-playing-d55d36d142955481 2026-09-17T04:15:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/c6051a8af9b974d2 2026-09-17T04:14:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/05ab89cd21c399c2 2026-09-17T04:13:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-morality-of-making-money-by-drug-companies-what-judges-say-61b4f0f088d8ff7f 2026-09-17T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-hidden-health-advantage-in-black-and-green-rice-a1d37df894608434 2026-09-17T03:52:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-the-pharmaceutical-industry-ushering-in-a-new-narrative-industry-giants-are-c-10a842d86305115c 2026-09-17T03:32:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-accelerates-global-access-planning-for-investigational-once-yearly-lenaca-490cc4e240733c69 2026-09-17T03:31:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/young-discusses-ships-for-america-act-at-hudson-institute-af2fe1a8917adc7f 2026-09-17T03:19:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/yakkyokukata-implementation-of-pdg-harmonized-texts-into-japanese-pharmacopoeia-648515e15bc0dc92 2026-09-17T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-cdx-approved-for-identifying-eligible-patients-updated-622cb0bc906cde46 2026-09-17T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-english-translation-of-review-report-opsumit-partial-change-approval-8b926a0ff49051b4 2026-09-17T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-list-of-approved-medical-devices-april-2004-to-december-2025-b9c1596fbadb2d5c 2026-09-17T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-21-09-e-23-09-controlli-gratuiti-per-prevenire-i-tumori-testa-collo-43d771103813000c 2026-09-17T02:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hidden-immune-organ-in-the-skull-may-help-fight-brain-cancer-cb58b17dbed624b7 2026-09-17T02:43:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-the-pharmaceutical-industry-embracing-a-new-narrative-industry-giants-are-col-2b76358db7efbe16 2026-09-17T02:36:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/anthropic-s-drug-discovery-partners-ai-pharmaceutical-orders-set-to-double-next-94b555d4be014da6 2026-09-17T02:10:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-korean-nuclear-test-sets-off-years-of-earthquakes-cf7db1f6465d1f2d 2026-09-17T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-forests-burn-can-we-replant-trees-ready-for-a-warmer-world-128739f835fd523d 2026-09-17T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-green-lights-1st-new-sunscreen-ingredient-in-years-4d1f139bc83cf3e9 2026-09-17T01:44:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/puma-biotechnology-nasdaq-pbyi-director-exercises-50k-options-sells-62k-shares-4587cf2f7f1ab95b 2026-09-17T01:13:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/working-with-emotional-intelligence-in-the-pharmaceutical-and-biopharma-industry-8a25c40b31642bdd 2026-09-17T01:01:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-to-support-the-protection-of-japanese-crested-ibis-habitats-for-the-16th-b696997410e8a3c4 2026-09-17T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/about-teva-pharmaceutical-industries-ltd-rstock-cc93b96ead8637d1 2026-09-17T00:57:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/greater-access-to-help-needed-for-women-with-nausea-during-pregnancy-44936c86b6095aaa 2026-09-17T00:42:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/bytedance-spin-off-ai-pharmaceutical-division-secures-massive-2-billion-yuan-fir-e94c7127fad69d8a 2026-09-17T00:30:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-unlp-busca-actualizar-el-sistema-de-boleto-educativo-gratuito-bb1a8f9c105b87b5 2026-09-17T00:18:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-de-su-asesinato-rendimos-homenaje-a-sergio-karakachoff-c0d9a09f2a74861f 2026-09-17T00:18:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/encuentro-de-secretarios-administrativos-por-la-nueva-ordenanza-101-a355412d3efc8e61 2026-09-17T00:16:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/inscripcion-al-jardin-maternal-de-la-unlp-745eaae45cdb5ef0 2026-09-17T00:12:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/se-prepara-la-segunda-jornada-de-deportes-electronicos-9d81b52f78266908 2026-09-17T00:11:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-krys-board-member-receives-new-options-and-rsus-0fda544b57675dd6 2026-09-17T00:07:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-fac321c3b6b02e2a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanofi-filed-form-6-k-d667b90b40c7dbc4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pioneering-research-team-and-emerging-scholars-lead-uct-s-success-at-nrf-awards-08f4f6f4a2c58d9b 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-for-microsatellite-instability-detection-in-precision-on-6a2a9824b5cf6d3d 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/levetiracetam-therapeutically-targets-gabaergic-synapses-in-diffuse-midline-glio-5521cb0cfbf33f83 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gene-editing-using-large-insertions-b56e263edfad4029 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-correction-genomic-deletion-of-malic-enzyme-2-confers-collateral-lethalit-464dd1ffc6734db4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-consumer-and-societal-values-perceptions-and-preferences-on-high-cost-ge-81b2d1eba7414653 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-a-team-of-ais-discovered-a-promising-lung-cancer-drug-6cf2b7d138e9d94e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-fast-are-you-ageing-ask-ai-86ffad19c6215ecb 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/take-a-risk-or-play-it-safe-neuronal-tug-of-war-helps-the-brain-decide-472015102d7f088a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/who-gets-credit-in-the-ai-era-openai-maths-bombshell-sparks-debate-337c4603c1cbf927 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mercury-is-shrinking-with-age-faster-than-thought-c1a37d230b37b35e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schoolhouse-meals-serve-up-an-income-bump-eee98c0d76e7273a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-new-evidence-for-hidden-chambers-beyond-tutankhamun-s-tomb-8c7871f23e0df62f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recommendations-for-the-development-of-blood-collection-processing-and-storage-s-b8c6b7db48c7e21e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-e6707987ea0046b9 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-exemption-from-premarket-notification-radiology-computer-aided-d-1da78c63c52f8524 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicare-and-medicaid-programs-application-from-dnv-healthcare-usa-inc-dnv-for-c-44f3c570867b78f3 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-information-collection-activity-diaper-distribution-demonstration-and-r-2a2324bd5db6fe4b 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/undersoker-sambanden-mellan-sociala-villkor-och-psykisk-ohalsa-9c4a5c6e43587264 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-undersoker-hur-matstrupscancer-kan-forebyggas-b2587fd59e8fa345 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kvinnor-upplevde-mindre-smarta-vid-spiralinsattning-med-ny-metod-94bbb5df87fc47e1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clintec-faculty-day-samlade-forskning-samverkan-och-framtidsfragor-d930cc81fe7effd5 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/brister-i-var-tredje-journal-vid-utredning-av-mojliga-cancersymtom-34d21f33f335d0a7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bengt-fadeel-keynote-talare-vid-eurotox-2026-2f5972eb8e18c29a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/doctor-debunks-popular-sleep-products-058798ff2943e079 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-novel-anti-cancer-agents-targeting-triple-negative-breast-cancer-2b40c9b7cbdecfb0 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/newer-antibiotics-for-drug-resistant-gram-negative-infections-in-immunocompromis-ac2c79a70fe51225 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incentivizing-challenging-drug-discovery-from-reducing-failure-to-quantifying-un-db5f865d210d7a05 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-safety-and-pharmacokinetics-of-bgm0504-a-dual-glp-1-gip-receptor-a-f1d9e7e14bcc5461 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-impd-deficiencies-in-the-clinical-trial-approval-process-2d5ea4123aeb939a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chitosans-and-chitosan-derivatives-in-pharmaceuticals-that-reached-clinical-tria-7dc4f0e025688551 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-virtual-biotech-a-multi-agent-ai-framework-for-therapeutic-discovery-and-dev-8aebfc32b4201382 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-olanzapine-on-chemotherapy-related-anxiety-in-pediatric-cancer-patien-ee558ad45c46ba67 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanostructured-lipid-carriers-for-intranasal-cannabidiol-delivery-in-dravet-and-b8989db3000516aa 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-response-screening-the-mmv-pathogen-box-reveals-the-mitochondrial-bc1-com-10cec4bb4b7e08bc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/screening-the-mmv-pathogen-box-reveals-the-mitochondrial-bc1-complex-as-a-drug-t-17cf47f0595fc2f2 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/respuesta-clinica-y-predictores-de-mortalidad-en-pacientes-con-ventilacion-mecan-bad3f71736007fb9 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/routine-immediate-postoperative-chest-radiography-after-minimally-invasive-pulmo-4aa500f12b8a1c92 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-systemic-oral-cellulose-based-superabsorbent-hydrogels-for-weight-management-1e7367eb1f656e51 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-and-mid-term-outcomes-of-primary-versus-redo-pericardiectomy-for-c-1a635c7aa54495a5 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-prosthesis-survival-after-total-hip-arthroplasty-in-young-women-with-d-319dd339550173cf 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spectrum-of-hereditary-ataxia-in-omani-children-46c98951ca8fdde4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incidental-misdiagnosed-intrahepatic-cholangiocarcinoma-and-combined-hepatocellu-c0bd4395c613f23d 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-diagnostic-delay-amplify-drug-resistance-in-tuberculosis-a-critical-integrat-e8ff8bb311e6bad4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-radiological-characteristics-of-pediatric-skull-fractures-and-their-ab36bd523cdbec99 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/organoboronic-acids-as-co-formers-in-pharmaceutical-crystal-engineering-d4e373881148a581 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interventions-to-reduce-antibiotic-prescribing-in-small-animal-veterinary-practi-4006c75ca92b7120 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/promater-protocol-for-a-randomized-controlled-trial-of-a-digital-self-guided-int-c7b2846433ae325f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-enabled-passive-digital-phenotyping-of-experiential-negative-symptoms-in-schi-9e28b9b0c36b8694 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/waveband-resolved-nonlinear-characterization-of-serf-magnetocardiography-signals-edca74eb526ec354 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-volume-ii-tumour-microenvironment-in-cancer-research-and-drug-discover-7fe50959d7c1a534 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-value-of-probiotics-as-adjunctive-therapy-for-diabetic-nephropathy-a-me-13c9984fdb8213cd 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-research-trends-in-tuberculosis-drug-resistance-mechanisms-a-bibliometric-a1b5946382edc9eb 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/off-target-drug-repurposing-for-rare-and-ultra-rare-cancers-towards-a-scalable-t-049d863795cd2bca 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-integrated-tam-aida-model-for-digital-health-technology-adoption-evidence-fro-27a9d20c4f65a064 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/risk-factors-and-short-term-outcomes-of-lower-limb-fractures-in-diabetic-patient-08bb6d6c5ead5d38 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacological-impact-of-mydriatic-drops-on-intraocular-pressure-variations-acr-21669ad105ec4b61 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unraveling-the-mystery-of-status-epilepticus-a-retrospective-study-at-a-tertiary-a9048ab8cd680ff1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microplastic-exposure-in-everyday-life-an-awareness-based-kap-study-among-the-in-46559a8bb0d2738f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-simulated-long-term-brushing-and-acid-exposure-on-the-surface-properti-202a2db61a3f0909 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-of-primary-headache-disorders-in-patients-with-epilepsy-and-res-b4e9273ab4be4795 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-predictors-of-early-multidomain-symptomatic-recovery-in-hospitalized-pa-35b55f37f9e3dce4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clinical-study-on-multidimensional-phenotypic-parameters-of-gender-and-age-dif-98810244e0a54730 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mind-over-cervix-using-virtual-reality-to-improve-anxiety-and-pain-during-outpat-f47ec1626d949d07 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-preoperative-coenzyme-q10-supplementation-on-oxidative-stress-and-wou-74761ebb3a19b789 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anatomical-features-and-hemodynamic-aspects-of-vascular-anastomoses-in-reconstru-5267a214891b3b54 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/to-eat-or-not-to-eat-dietary-patterns-and-the-clinical-recognition-of-insulinoma-77c4e9d24c7b9904 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypercholesterolemia-in-underweight-individuals-mechanisms-clinical-significance-f5008e8cc58ce6a6 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasopharyngeal-carcinoma-epidemiology-risk-factors-signaling-pathways-clinical-f-9be3d020f20b2d04 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-clinical-education-assce-a-scoping-review-of-use-and-experiences-o-3e91b28930af36ca 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/express-longitudinal-circulating-mirna-profiling-identifies-pharmacodynamic-biom-b4eccbcf06de3c8e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-kidney-health-in-focus-a-scientific-statement-from-the-american-heart-as-528fafe1392aeedc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/local-and-systemic-risk-factors-of-dental-biofilm-induced-gingivitis-and-their-c-3aa6ba93a69d0a95 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-the-long-term-risk-of-type-2-diabetes-and-cardiovascular-disease-with-278ebe7d9c1b0a9e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurofeedback-for-functional-neurological-disorders-future-directions-for-resear-9f18be548ab7c6f8 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/water-and-liquid-soap-cleaning-of-removable-orthodontic-appliances-a-triple-blin-f4be5b10c5e36833 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-microbiologic-predictors-of-progression-to-infection-among-children-981a1a8b318f2fc1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-internal-validation-of-an-ehr-machine-learning-model-for-clinica-f6dc3fc0d96a01f1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-a-three-month-exercise-programme-on-cognition-mood-and-neurogenesis-t-d2be6075925e41cc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-endogenous-carbon-monoxide-for-cancer-selective-drug-synthesis-23780c69301d10a7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modulating-the-periodontal-wound-microenvironment-through-oxygen-therapy-a-narra-c1466eabbd8e63ab 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-dual-role-of-cholesterol-metabolism-in-hepatocellular-carcinoma-mechanisms-t-52c334fe86bb524b 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interpreting-positive-and-inverse-disproportionality-signals-in-spontaneous-repo-1200b13c43ca8e4c 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glucagon-like-peptide-1-receptor-agonists-and-neovascular-age-related-macular-de-525d52014b3f883c 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sub-acute-clinical-leaflet-thrombosis-after-transcatheter-aortic-valve-implantat-c4a7c6391d426847 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-buffered-vs-non-buffered-4-articaine-local-anaesthetic-solution-in-a-4ab465f7d4e61830 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/surgical-resection-of-a-liver-metastasis-from-an-ovarian-granulosa-cell-tumor-mi-72fc1923a67b60b6 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-silico-and-hansen-solubility-parameters-guided-hme-3d-printed-tablets-boostin-30492068315baa08 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-import-forecasting-for-supply-chain-decision-support-a-comparativ-1fbb7af35c0e9d08 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-vitro-anti-inflammatory-evaluation-gene-expression-hr-lc-ms-profiling-and-in-3d700e8cd593a619 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-agroenvironmental-clinical-link-of-proteus-mirabilis-genomic-epidemiology-cl-b5598d5aee03a1b2 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-utility-of-magnetic-resonance-enterography-for-pediatric-crohn-s-diseas-87bd48bb81c7cd25 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-development-and-optimisation-of-an-amorphous-solid-dispersion-based-etori-91b0613d64d9403e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-clinical-mediation-in-end-of-life-disputes-a-procedural-justice-analysis-bd4d4e19235b69df 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07826130-nano-silver-fluoride-and-photobiomodulation-therapy-for-hypersensiti-b4a4f724abc4bfdc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07825870-outcomes-of-fluoroscopy-guided-transdiscal-splanchnic-nerve-neurolys-3f7abb7852e2ca56 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07825701-individual-patient-expanded-access-for-velzatinib-gsk6042981-in-pati-2ea78bb102116063 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07825064-cevostamab-in-combination-with-pomalidomide-and-dexamethasone-after-77853e3edda2daa1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823959-cbc-based-inflammatory-indices-in-newly-diagnosed-multiple-myeloma-375a05e3b59697a6 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07767890-a-study-of-the-safety-and-effectiveness-of-onasemnogene-abeparvovec-4ce5877dc35d6e35 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07660081-effects-of-acetyl-l-carnitine-supplementation-on-clinical-metabolic-b7ede323169891dc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07659782-a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-non-sm-18e7ce25a19f9095 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07656636-perforated-appendicitis-and-postoperative-antibiotics-pilot-trial-8d7d89a727dcd441 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07630974-a-study-of-ifinatamab-deruxtecan-in-pediatric-participants-with-rela-ebb34d1e74d8f582 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07625644-bl-m14d1-plus-atezolizumab-vs-standard-of-care-in-first-line-extensi-c2a444214ae9ea17 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07596849-a-study-to-assess-efficacy-and-safety-of-efgartigimod-ph20-sc-pfs-in-a040a5fe30d6eb53 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07574541-multitargeted-recombinant-ad5-psa-muc-1-brachyury-based-immunotherap-0f3af0b930fedd23 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07545291-a-spiritual-health-intervention-path-for-improving-spiritual-religio-655772e97f709724 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07524530-stem-cell-transplantation-for-participants-with-germline-runx1-assoc-f7c7537ec91ee762 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07519772-a-clinical-study-of-mk-1045-in-people-with-non-hodgkin-lymphoma-mk-1-a50ac56f09684b1d 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07505706-patient-journey-in-palliative-care-within-the-novo-hospital-group-32ce4588df512269 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07490860-a-restorative-justice-based-lung-cancer-screening-decision-making-su-2fd16cf28dd0e41c 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07456696-an-evaluation-of-the-safety-and-efficacy-of-tsnd-201-for-the-treatme-311ad94fea94556e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07361432-digital-treatment-for-chronic-pain-and-addiction-in-veterans-with-op-e6b77566701e13ee 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07339111-phase-3-pivotal-trial-comparing-cartistem-and-surgical-comparator-fo-b4f1a62c1bd31e3a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07289243-treatment-for-benign-prostatic-obstruction-transperineal-laser-ablat-87889351226ce165 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07227415-symbiotic-gu-08-a-study-to-learn-about-the-medicine-called-pf-086344-31b83c018be3344a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07172802-a-study-of-gi-108-an-anti-cd73-igg4-fc-il-2v-bispecific-fusion-prote-a9136767e2878860 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07049926-substudy-03c-a-study-of-combination-therapies-in-participants-with-r-9a8ad78617f16916 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06991738-177lu-dota-eb-tate-in-adult-patients-with-metastatic-radioactive-iod-8bb88397e09523fd 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06952504-a-study-to-compare-sacituzumab-tirumotecan-mk-2870-in-combination-wi-e71573a13633e252 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06904066-autologous-t-cells-transduced-with-retroviral-vectors-expressing-tcr-8a1bed717e911091 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06790498-long-term-follow-up-study-of-participants-exposed-to-renal-autologou-eceefa5a26235e17 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06733363-a-cruciferous-vegetable-eating-program-for-the-reduction-of-cancer-r-2e0ed65d37bf5c25 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06695897-a-non-interventional-observational-study-to-assess-long-term-efficac-989a95c98505c144 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06672146-comparing-new-treatments-for-people-with-newly-diagnosed-acute-myelo-51f701006c42f5e7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06671483-a-study-of-zasocitinib-in-adults-with-psoriatic-arthritis-who-have-n-1c4edd0ea261b148 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06668558-venetoclax-azacitidine-in-patients-with-acute-myeloid-leukemia-6ae38f1adf5a26be 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06623409-safety-and-immunogenicity-of-v540b-in-healthy-adults-v540b-002-0be620543c58503a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06615973-screening-for-social-determinants-of-health-sdoh-and-cognitive-funct-69af5e89852e6a1a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06607003-induced-blood-stage-malaria-in-healthy-malaria-naive-adults-to-asses-7e071e53d6f06a4c 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06605222-a-trial-of-shr-7787-injection-in-patients-with-advanced-solid-tumors-92aa4f67912a2b5b 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06583018-mindfulness-based-lifestyle-modification-programme-for-caregivers-of-b685dc0802101154 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06529523-tislelizumab-in-people-with-colorectal-cancer-be34c9bd54aa73d7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06353386-substudy-01a-safety-and-efficacy-of-opevesostat-mk-5684-based-treatm-cf0dc71aa337d086 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06148025-antibiotics-and-vaccine-immune-responses-study-4cacf1b74715f1ac 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06098833-treatment-of-neonatal-encephalopathy-with-oral-sildenafil-suspension-266e9b61d1feb456 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05902351-natural-history-study-for-charcot-marie-tooth-disease-9441c73624d11e73 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05744921-a-study-in-adult-patients-with-paroxysmal-nocturnal-hemoglobinuria-p-cae51eeebebbb8c7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05713799-trial-of-the-combination-of-alpha-lipoic-acid-and-mirabegron-in-wome-58ca62d5ec6a8459 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05603728-exactech-shoulder-post-market-clinical-follow-up-study-2904fd6614d479e2 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05564377-targeted-therapy-directed-by-genetic-testing-in-treating-patients-wi-2008e0086f4d7541 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05492851-trial-comparing-three-single-dose-injections-for-knee-osteoarthritis-de11a108dbea0d77 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05267639-clinical-outcomes-with-passive-mpks-vs-powered-prosthetic-knees-dd38e09a93e675aa 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05136196-bicazo-a-study-combining-two-immunotherapies-cabozantinib-and-nivolu-3eb3d3ab47dbf20d 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04638803-a-phase-0-open-label-crossover-microdose-pharmacokinetic-study-of-pr-4b9d4c2f14fe6101 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04269902-testing-early-treatment-for-patients-with-high-risk-chronic-lymphocy-cf81092206932f4e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00921232-assessment-of-the-burden-within-the-dyad-patient-caregiver-f81c9d6a05b874bf 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sputum-based-test-may-identify-drug-targets-in-asthma-and-copd-patient-care-onli-b5536bfbcfaf8e3f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-sanofi-gilead-weigh-ai-readiness-and-validation-risk-at-pda-fda-conference-f9f6c159e3cb593a 2026-09-16T23:51:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-announces-personnel-change-956652823d3f43cd 2026-09-16T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-s-lab-made-antibody-shot-for-celiac-shows-hopeful-results-ecbc01d07dffb77c 2026-09-16T22:36:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/pedro-resources-takes-250k-bridge-loan-from-insiders-as-it-eyes-biotech-pivot-9861b7f2fe548a26 2026-09-16T22:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-receives-4-2-million-nih-award-to-continue-all-of-us-enrollment-883c35c953fde48c 2026-09-16T22:05:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/convegno-21-09-fattori-di-rischio-e-differenti-scenari-nella-masld-una-sfida-quo-9b5ebdf1cefe3ce4 2026-09-16T21:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-biotech-s-us-75-000-second-life-23b198dbdacbdaef 2026-09-16T21:58:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/iconthin-biotech-marks-10-years-of-microalgae-innovation-as-astadaily-expands-ca-b776a2d708fd1090 2026-09-16T21:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-hit-with-lawsuit-over-its-proposed-opdivo-biosimilar-1f2484de4e80d755 2026-09-16T21:23:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-ipo-stock-tracker-how-newly-public-biotechs-are-performing-077ec10ed091a6c5 2026-09-16T21:10:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-zhejiang-anglikang-pharmaceutical-co-ltd-class-a-stocks-0cba90adc2365995 2026-09-16T20:53:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-finance-netherlands-ii-issues-eur-1-bln-of-4-250-senior-note-0f9644fe8abe7fc0 2026-09-16T20:39:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/use-of-probenecid-as-an-anti-virulence-agent-against-listeria-monocytogenes-3bfbddee45820887 2026-09-16T20:35:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/hawley-pushes-republicans-to-back-national-abortion-pill-ban-99866c89c28fe8a0 2026-09-16T20:32:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/ada-family-day-at-the-dallas-zoo-d802a9e5bea6be67 2026-09-16T20:29:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-this-biotech-stock-just-got-a-rare-double-upgrade-7e7dcd156623785d 2026-09-16T20:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-comemora-20-anos-do-curso-de-biblioteconomia-e-gestao-de-unidades-de-inform-aa541f68d0cecdb6 2026-09-16T20:18:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/telix-pharmaceuticals-buy-on-pixclara-fda-approval-and-tlx591-tx-part-2-advancem-e547720d3a6557d1 2026-09-16T20:10:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-tar-heel-army-rotc-cadets-earn-recondo-badge-baaf02bcf6b204ed 2026-09-16T20:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-75-million-payment-is-triggered-as-innate-pharma-starts-a-cancer-trial-81224f5f9fdca6c4 2026-09-16T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ers-2026-obesity-an-independent-obstruction-to-biologic-treated-asthma-8fe9aca8139f27b2 2026-09-16T19:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-researchers-to-establish-countywide-effort-to-catch-early-warning-sign-310e63d12e70c99b 2026-09-16T19:35:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/breakthrough-study-finds-possible-causes-of-cardiac-fibrosis-in-hlhs-fb08546c24883418 2026-09-16T19:28:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-withdraws-publication-of-covid-shingles-vaccine-research-findings-0c9137b444e2e92a 2026-09-16T19:20:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-saint-joseph-hospital-earns-magnet-recognition-with-distinc-3c60775d657ec064 2026-09-16T19:18:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/litigation-involving-reproductive-health-and-rights-in-the-federal-courts-8a4c7a103016ef0f 2026-09-16T19:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-ropes-in-123m-for-oral-thyroid-eye-disease-drug-545cdd139d817376 2026-09-16T19:11:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/mayer-brown-represents-underwriters-on-teva-pharmaceutical-s-us-4-9-billion-seni-3890078c3ce9091a 2026-09-16T19:09:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-good-samaritan-hospital-introduces-ladies-night-out-f12b373d9531245f 2026-09-16T18:58:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/thanks-trump-why-canada-may-become-the-european-union-s-first-ever-associate-mem-159cd5ace0912083 2026-09-16T18:56:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/tauber-se-reunio-con-la-vicegobernadora-bonaerense-veronica-magario-bc55f6fe953d0941 2026-09-16T18:48:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-conversation-with-scientific-advisory-board-member-and-evolutionary-biologist-78e562fb61dca9a4 2026-09-16T18:40:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-gains-a-way-to-get-drugs-into-the-brain-buying-sironax-tech-for-125m-29a20728c63ef2a3 2026-09-16T18:35:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-kagoshima-university-explore-new-areas-for-research-and-training-collabora-7f84458cdc414908 2026-09-16T18:24:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-ever-drug-to-treat-life-threatening-disease-a-landmark-moment-47b6edd63729a568 2026-09-16T18:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-rafiki-holds-a-workshop-to-advance-drug-discovery-and-development-in-afric-6ae1b0a8fe5e9c37 2026-09-16T18:14:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-fortalecio-la-cooperacion-regulatoria-regional-en-la-reunion-anual-latinoa-a27b9b1eefa3aeaa 2026-09-16T18:07:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-car-in-your-garage-can-power-your-house-66c17fe910c507ab 2026-09-16T18:04:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrate-university-day-at-the-bell-tower-at-night-178b10df9de9e5e2 2026-09-16T17:53:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-pulse-behind-the-scenes-of-logipharma-usa-2026-d71d1ef69cd0003a 2026-09-16T17:43:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-and-partners-launch-handbook-to-strengthen-suicide-prevention-088712614b0aebed 2026-09-16T17:38:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/looking-beyond-short-term-turmoil-syngene-is-investing-for-the-future-ff2542fffd1088f1 2026-09-16T17:28:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-nih-funding-crisis-that-could-reshape-biotech-for-years-to-come-b62b5f7bdd7a60de 2026-09-16T17:21:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-vivs-fda-approvals-pdufa-dates-drug-alerts-2026-vivs-9890ddb010a5431b 2026-09-16T17:18:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypertension-clinical-trial-pipeline-accelerates-as-100-pharma-companies-rigorou-0af55f774e29cf90 2026-09-16T17:15:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/examination-of-import-data-chemical-compounds-in-medicines-commonly-advertised-t-763641fbdc28ea5a 2026-09-16T17:14:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-will-novo-nordisk-be-in-5-years-as-the-glp-1-market-gets-more-crowded-b3961869c0ece775 2026-09-16T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korea-s-first-homegrown-obesity-drug-eppe-set-for-launch-this-year-challen-ab6bb3ea6dbff378 2026-09-16T16:58:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/617-billion-longevity-biotech-market-takes-shape-72fd4fdc99cabefc 2026-09-16T16:56:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-s-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogren-s-investors-c33dcbb7609e0cdd 2026-09-16T16:42:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pressure-cooker-pilot-destroys-pfas-in-sewage-but-scaling-up-is-a-challenge-e31e555c4cc81f97 2026-09-16T16:32:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-sucker-s-dilemma-the-psychology-of-getting-conned-e818af4adb86d4fd 2026-09-16T16:31:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/mamdani-s-consumer-cop-brings-lina-khan-s-playbook-to-nyc-5101674923b0f52e 2026-09-16T16:30:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-biotech-smidcap-stock-mizuho-analyst-highlights-immx-1a04bb2a75230e6e 2026-09-16T16:29:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-sustainability-modular-design-transform-pharmaceutical-manufacturing-094f4e78a7fc3cd5 2026-09-16T16:27:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/expanding-statewide-efforts-to-improve-heart-health-bbfbb0b44276a31f 2026-09-16T16:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-will-novo-nordisk-be-in-5-years-as-the-glp-1-market-gets-more-crowded-64b65b9c3b270224 2026-09-16T16:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ingrid-zhang-a-new-leadership-chapter-at-legend-biotech-5d204a30db404f28 2026-09-16T16:14:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/ammonium-sulfate-fermentation-market-forecast-to-2035-biotech-demand-drives-grow-7089e7cb4d4ed2cf 2026-09-16T16:01:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-accelerates-biotech-promise-increasing-security-risks-86b42c82b5278c6d 2026-09-16T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-recipient-honours-organ-donors-with-transplant-games-overture-91018807af22fe2f 2026-09-16T15:50:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-reaches-hiv-prep-agreements-hong-kong-investigates-cloudbreak-ipo-9f9b09cdff1fc0b2 2026-09-16T15:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sicadi-resultados-de-categorizacion-de-docentes-investigadores-as-de-la-unlp-e34068010678089c 2026-09-16T15:36:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-treatments-drive-smarter-sustainable-pharmaceutical-packaging-38172df7a6199e47 2026-09-16T15:34:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/raw-material-complexities-and-strategies-with-for-advanced-therapies-75982b30edb4c2d1 2026-09-16T15:33:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/legionellosis-in-residents-of-england-and-wales-2025-ddbdab6f2a833e23 2026-09-16T15:33:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasa-hubble-fellowship-program-2027-803e4575d6d906d0 2026-09-16T15:25:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-counting-sheep-to-forty-winks-three-tips-to-get-your-kids-back-on-a-healthy-a507f783ecee492d 2026-09-16T15:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cooking-class-livestream-italian-ground-turkey-frittata-d84cf9acb61ad274 2026-09-16T15:09:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-adrs-inched-up-as-telecom-and-biotech-led-472ac474aa915400 2026-09-16T15:08:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/montana-s-giving-the-biotech-industry-sweeping-authority-to-sell-unapproved-drug-2190e459be361d76 2026-09-16T15:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/naoko-takebe-md-phd-joins-wilmot-to-build-early-phase-clinical-trials-and-develo-7441cb8dd9acd00e 2026-09-16T15:04:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/cold-mortality-monitoring-report-england-winter-2024-to-2025-6966878552215588 2026-09-16T15:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/kibow-biotech-wins-2026-webaward-for-best-science-website-52d6a8ecf05d157c 2026-09-16T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1s-what-is-behind-the-variation-in-efficacy-f2db9c17e19f1a25 2026-09-16T14:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/bauchaortenaneurysma-nach-evar-neue-wege-zur-besseren-nachsorge-fad268c1acffb4b9 2026-09-16T14:57:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-shortages-a426e4f99d62d81a 2026-09-16T14:50:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/law-firm-leader-to-chair-2026-long-island-heart-stroke-ball-ff797735c0b6f755 2026-09-16T14:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivre-avec-et-apres-un-cancer-les-promesses-et-les-defis-de-la-sante-numerique-945e8a65c5d7a4f3 2026-09-16T14:46:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/estates-safety-fund-initial-schemes-and-associated-funding-allocations-2026-to-2-578511fd55580096 2026-09-16T14:42:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-ends-als-program-after-phase-2-flop-adding-to-r-d-woes-da0b1c01b0e1cfd3 2026-09-16T14:28:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/buy-european-incentivising-eu-based-pharmaceutical-manufacturing-f0be7ec5d4a13c8d 2026-09-16T14:23:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/people-on-the-move-ingrid-zhang-named-chief-executive-officer-of-legend-biotech-fa8e3ddf53ecd71a 2026-09-16T14:17:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-first-patients-dosed-in-global-phase-3-orbit-pivota-493b66e4547da753 2026-09-16T14:12:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-names-novartis-veteran-ingrid-zhang-as-new-ceo-c36c83304cfb057b 2026-09-16T14:12:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/rassegnastampa-disagio-adolescenziale-in-lombardia-25mila-accessi-in-ps-policlin-daa6272d4426e2dc 2026-09-16T14:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acrp-unveils-theme-for-2027-annual-conference-d04f966c0b3615d9 2026-09-16T14:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-an-immune-false-alarm-that-may-drive-rapid-aging-00104e3c1b86bb4e 2026-09-16T14:05:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-engineered-bacterial-symbiont-maps-micron-scale-sugar-gradients-in-the-honeyb-c00843ed0d57862a 2026-09-16T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-a-phage-anti-defense-weapon-into-an-immunity-trigger-93d45ca39f2aeaae 2026-09-16T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spamoal-is-a-deep-learning-method-that-enables-accurate-spatial-domain-identific-cf38688d6c4c0b39 2026-09-16T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-what-holds-us-on-iphone-18-pro-f697be91e8bd515c 2026-09-16T13:59:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/supreme-court-preserves-broad-access-to-abortion-drug-mifepristone-7f64cc35a1f5e3e3 2026-09-16T13:58:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/carolina-housing-is-built-on-student-feedback-2c16247fc949a7a2 2026-09-16T13:58:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/eschback-launches-leader-standard-work-capability-in-seqonis-platform-d6bbb1809a7eb5ff 2026-09-16T13:54:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-examination-results-top-position-for-heidelberg-medical-students-53c49699f7c9000c 2026-09-16T13:54:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/collegium-pharmaceutical-at-h-c-wainwright-pushing-beyond-pain-by-investing-com-7acb87745e02bc6a 2026-09-16T13:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/arrowhead-achieves-clinical-validation-for-new-drug-platform-a8d024929ce7f48e 2026-09-16T13:39:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/sen-warren-demands-to-see-trump-drug-pricing-pharma-contracts-accuses-rfk-jr-of-b2c1b39832ead5db 2026-09-16T13:36:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-launches-phase-3-mdma-assisted-therapy-trial-for-ptsd-targeting-ve-9bb879d09f021f92 2026-09-16T13:35:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-can-our-genes-tell-us-about-preventing-myeloma-fb0d068098d74476 2026-09-16T13:31:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/10-ai-biotech-firms-in-northern-metropolis-to-get-early-cross-border-data-access-8d6ce46540846e4e 2026-09-16T13:31:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-risks-provider-misconduct-and-a-21-year-old-s-death-sharpen-safety-warning-5194dfbd227784a9 2026-09-16T13:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-risks-provider-misconduct-and-a-21-year-old-s-6b7a9c26ed278664 2026-09-16T13:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccination-information-for-healthcare-practitioners-2a8cecfc3a4c1e42 2026-09-16T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pbm-entity-no-pharmaceutical-company-directly-contracted-with-15e0f87edc35ede0 2026-09-16T13:18:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-submission-advice-support-for-innovative-medicines-b8e46373a16aa9af 2026-09-16T13:16:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-assessment-procedure-for-medicines-5034d11e20bd2b10 2026-09-16T13:15:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-pre-market-movers-meds-tpst-cupr-chart-the-course-b8cbe9650f92187b 2026-09-16T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicines-apply-for-a-variation-to-your-marketing-authorisation-bc0e2a85d91fcf38 2026-09-16T13:14:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-projet-de-recherche-pour-en-finir-avec-le-risque-de-noyade-des-personnes-lary-6ad6ce0ec9a9cf84 2026-09-16T13:13:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-names-ex-novartis-exec-as-ceo-601341f40ad47d08 2026-09-16T13:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/calgary-based-biotech-founders-announced-as-recipients-of-canada-s-top-40-under-01c6c7755adde338 2026-09-16T13:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinphar-pharmaceutical-fy2026-h1-earnings-call-gross-margin-hits-record-45-4-aug-2c92cc8d92f59c34 2026-09-16T13:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-locks-down-120m-pact-to-deploy-automated-production-platform-for-unnamed-com-dedd8983f9a5d6b6 2026-09-16T13:02:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/notifiable-diseases-causative-agents-reports-for-2026-32900b46450305d4 2026-09-16T13:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccine-5-years-and-over-pgd-and-vgd-6776102a716b3a92 2026-09-16T13:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-the-green-book-chapter-d276b249e49e4dc1 2026-09-16T13:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/finally-a-chance-to-breathe-christiana-gets-care-for-hirschsprung-s-disease-c3e13beb67f44b5a 2026-09-16T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-manufacturing-plant-setup-in-india-9388a1cfa87e6157 2026-09-16T12:54:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-the-whole-grain-sweet-spot-for-better-heart-health-74fe8c2892b5b3af 2026-09-16T12:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-concede-titulo-de-professora-emerita-a-ana-luiza-coelho-netto-07641e2218bdf689 2026-09-16T12:52:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncology-biotech-news-key-moves-to-watch-in-september-2026-78cb8609a164864f 2026-09-16T12:42:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-cuts-98-scottsdale-jobs-after-product-sale-02c12ed5bda7592e 2026-09-16T12:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-pays-sironax-125m-to-acquire-platform-for-crossing-the-blood-brain-barr-57efc9bfdd6fbe18 2026-09-16T12:32:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ciclo-de-talleres-para-investigadores-de-la-unlp-2026-tercera-edicion-d1bb67ca66d66070 2026-09-16T12:31:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-unveils-new-namkindtm-drug-toxicity-data-at-eurotox-2026-demonstrat-7c307c64eb413c4e 2026-09-16T12:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/curiosity-guides-law-school-s-first-strait-fellow-1018a0e7604d6563 2026-09-16T12:26:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-opth-lines-up-phase-3-mdma-ptsd-trial-for-veterans-5e5dca7bb97f51cb 2026-09-16T12:25:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-expands-clinical-program-with-phase-3-trial-evaluating-mdma-assist-3138d9050b7df197 2026-09-16T12:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenetic-to-merge-with-santersus-ceding-85-of-combined-biotech-to-swiss-investors-38ce4de6437ed570 2026-09-16T12:21:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/without-bacteria-or-chemicals-how-methanol-and-formaldehyde-form-abiotically-in-8f865ceb512ae516 2026-09-16T12:07:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-human-gut-model-detected-drug-toxicity-before-cells-were-harmed-49f74bd75e06bac9 2026-09-16T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-unveils-new-namkindtm-drug-toxicity-data-at-9728338ec7150c0b 2026-09-16T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezera-announces-plans-to-launch-the-reveal-pad-multi-center-study-investigating-8bbac5a19abb9435 2026-09-16T12:04:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/kendall-square-biotech-incubator-launches-program-to-draw-international-startups-e128c3dc2e07ddaa 2026-09-16T12:00:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/rolling-with-the-waves-ac90c33b7cf09730 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-experiences-accessing-health-information-online-trusted-sources-and-cont-1be2bf56f59deca5 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/platinum-naturals-easymulti-stress-men-affected-lots-incorrectly-labelled-for-vi-317c64c8990d36f5 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ndi-passive-spherestm-2106148f4021c722 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intellispace-critical-care-and-anesthesia-0d5a41697926527e 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ceo-o-day-tells-fierce-how-gilead-s-cancer-inflammation-expansion-has-reached-cr-7c635c6900bbfbe7 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-banana-faces-an-existential-threat-can-biotech-save-it-6fa7858cd1651577 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-accelerates-supply-chain-heat-decarbonization-e278b969d389bded 2026-09-16T11:51:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-dr-jakob-nikolas-kather-wird-hopp-stiftungsprofessor-fur-kunstliche-in-8b53026d890c4691 2026-09-16T11:50:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-west-pharmaceutical-services-stock-outperforming-the-nasdaq-0f730f5a4482fb08 2026-09-16T11:50:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/globalpharma-and-princefarma-sign-mou-to-advance-pharmaceutical-distribution-in-e4c13edf0ce21061 2026-09-16T11:48:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-memoriam-rob-van-der-wal-8b01f45490929bc1 2026-09-16T11:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-activation-of-university-of-florida-health-as-newe-84699260c629525c 2026-09-16T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ascendis-regains-obesity-rights-as-novo-exits-monthly-glp-1-deal-cf9dc0b84009e824 2026-09-16T11:27:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/opportunities-for-patients-and-the-public-to-be-involved-in-the-work-of-the-mhra-f3c0f65f319949e0 2026-09-16T11:27:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/rs-11-iv-sold-for-rs-325-maharashtra-fda-chief-tukaram-mundhe-flags-huge-markup-55f2cfe5530ce4a7 2026-09-16T11:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-s-5bn-scaleup-fund-will-not-fix-biotech-s-funding-gap-even-its-backers-sa-4944433c0dc34ac8 2026-09-16T11:17:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-sek19-3m-to-13-guarantee-and-a-sek50m-equity-facility-5269a621b698e7d9 2026-09-16T11:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-first-patients-dosed-in-global-phase-3-orbit-pivota-d75552e00382cd47 2026-09-16T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidance-national-patient-safety-alert-supporting-information-patient-hoists-and-481832dd1483a5a5 2026-09-16T11:04:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-patient-safety-alert-patient-hoists-and-slings-all-types-risk-of-death-96b745c6c3886211 2026-09-16T11:01:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-neurons-flourish-in-mouse-brains-offering-a-new-view-of-neurodevelopmental-ee7d34769d2e1775 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-123-million-series-c-financing-to-advance-phase-3-d-5cf553c7190d4864 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-gets-123m-for-phase-3-trial-of-ex-astellas-drug-in-thyroid-eye-disease-3e28cc7677d34261 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-acquires-covetai-to-advance-veterinary-workflow-intelligence-81cfc6189054a50d 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-la-actualizacion-de-la-informacion-de-seguridad-de-los-medic-9860b82efb555986 2026-09-16T10:59:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-dividend-1d1e3cf8ca63c361 2026-09-16T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-reels-in-123m-series-c-to-fund-oral-tepezza-rival-through-phase-3-trial-7ef90bc333acc0d4 2026-09-16T10:57:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-recuerda-como-evitar-errores-de-medicacion-por-sobredosificacion-con-vi-e10c84f344062da2 2026-09-16T10:47:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/msd-7b118228b3a79e32 2026-09-16T10:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sclerodermia-humanitas-partecipa-alla-giornata-del-ciclamino-ef1b80297605f7c9 2026-09-16T10:42:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/six-neighbourhood-health-trailblazers-to-transform-care-e6da2526d470fa64 2026-09-16T10:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-announces-fda-clearance-for-ligasuretm-ras-maryland-instrument-on-the-adeda03ace33da07 2026-09-16T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-harpnet-harnessing-resolution-pharmacology-for-next-generation-th-ca5334805d0493f8 2026-09-16T10:27:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-you-invest-in-the-vaneck-biotech-etf-bbh-03686cfedea3aa38 2026-09-16T10:20:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/ingrid-zhang-appointed-ceo-of-legend-biotech-amid-mid-september-2026-industry-le-5ed0fa87667a5ca9 2026-09-16T10:15:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/tv-drug-ads-could-lose-their-website-shortcut-for-risk-details-under-an-fda-rule-bc0a0495d16ec398 2026-09-16T10:15:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/9ad3c82bb027f830 2026-09-16T10:08:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-warnt-vor-personalabbau-und-schlechterer-patientenversorgung-954f5acc34729d49 2026-09-16T10:07:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/8f0cd19707f1caf3 2026-09-16T10:06:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/775198a373c05713 2026-09-16T10:05:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/4644adfcfbaf2ab9 2026-09-16T10:03:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ctt-pharma-corporate-updates-7cb9f05535b4eb81 2026-09-16T10:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-for-medicines-good-clinical-practice-inspections-a1362df4adb5e02b 2026-09-16T09:36:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/reunion-del-comite-de-medicamentos-de-uso-humano-de-septiembre-de-2026-cf9a2cb6077912c0 2026-09-16T09:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kim-yong-min-named-2026-jw-sungcheon-award-recipient-85a5f990849a0bc3 2026-09-16T09:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharmaceutical-wins-2026-national-contribution-award-05149f7f49635776 2026-09-16T09:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kpbma-holds-korea-thailand-pharmaceutical-forum-in-bangkok-ec594cbe6f8df10b 2026-09-16T09:26:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/quotient-sciences-named-among-gen-s-10-cdmo-up-comers-2026-b8121582b4e6e4a1 2026-09-16T09:26:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-holds-public-hearing-on-psychedelic-drugs-as-trump-driven-push-gathers-pace-c37ed3be97b94076 2026-09-16T09:25:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/uusi-maisteriohjelma-tarjoaa-ruokaviennin-kansainvalista-osaamista-00472ee05d3deed5 2026-09-16T09:23:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-is-reshaping-the-cdmo-sponsor-relationship-dbb6c49855c23d14 2026-09-16T09:10:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/gewebeproben-mit-ki-besser-verstehen-und-fur-schnelle-diagnostik-in-der-klinik-n-625e35e46fdfa6ca 2026-09-16T09:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esophageal-cancer-d33c851864a42cf9 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/trial-of-a-maternal-diet-rich-in-eggs-and-peanuts-to-reduce-infant-allergy-6e5f763803c3f227 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/blinatumomab-for-replacing-chemotherapy-in-pediatric-acute-lymphoblastic-leukemi-656f2fd54806b226 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/colonoscopy-intervals-and-colorectal-cancer-incidence-after-adenoma-removal-b01c3d5581aa8100 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/late-onset-pompe-disease-404537abf6a4be48 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/blinatumomab-a-new-standard-of-care-in-acute-lymphoblastic-leukemia-61676a3aac71c835 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/sodium-bicarbonate-in-critical-illness-a-new-chapter-for-the-book-2b3d56ad81f12f4a 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/maternal-allergen-consumption-and-infant-food-allergy-reassurance-not-prescripti-5027d4c78ebd64f4 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-more-is-not-better-colonoscopy-surveillance-after-high-risk-adenomas-72846a6bb69fea41 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-26-2026-a-62-year-old-woman-with-memory-loss-anhedonia-and-temporal-wasting-27613684b99c331b 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/initial-screening-for-colorectal-cancer-a0055ed7a0c3aafa 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/endovascular-therapy-for-post-thrombotic-syndrome-a-randomized-trial-fc9f3efb263205d3 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/antidotes-for-anticoagulation-reversal-dc97b7c61919c4af 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-atrial-appendage-closure-or-anticoagulation-for-atrial-fibrillation-e09511939c474025 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/kidney-transplantation-in-highly-sensitized-persons-after-car-t-cell-therapy-8d07755a7813a838 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-adenovirus-b3-induced-immune-thrombocytopenia-and-thrombosis-95f0f6ec097ad37b 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/colorectal-cancer-risk-among-patients-with-serrated-polyps-896d7970ef229514 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-we-underestimating-the-pharmaceutical-potential-of-the-cannabis-plant-579d1a341447e83f 2026-09-16T08:47:26.000Z weekly 0.7